8.1 - GI Disorders

Summary

GASTROINTESTINAL, HEPATIC, AND BILIARY DISORDERS IN PREGNANCY

TopicPathogenesisClinical ManifestationsDiagnosisTreatment / Management
Hyperemesis GravidarumRelated to high/rapidly rising hCG, estrogen, and progesterone; possibly linked to Helicobacter pylori or psychological factors.Severe unrelenting nausea/vomiting, weight loss >5%, dehydration, ketonuria, electrolyte imbalance, hypokalemia, and alkalosis.Diagnosis of exclusion; must rule out other causes of persistent vomiting.1st line: Diclegis (Doxylamine + Pyridoxine). IV crystalloids (D5LR/D5MN) for dehydration. Thiamine (100mg) for Wernicke prevention.
GERDRelaxation of the lower esophageal sphincter (LES) due to progesterone and increased intraabdominal pressure from the uterus.Heartburn (pyrosis), retrosternal burning, and chest pain; prevalence increases toward the 3rd trimester.Primarily clinical; rule out preeclampsia/appendicitis for epigastric pain. Endoscopy if symptoms persist.1st line: Oral antacids. PPIs (Pantoprazole/Omeprazole) and H2 blockers (Famotidine) are safe. Avoid Misoprostol.
Peptic Ulcer Disease (PUD)Caused by H. pylori or NSAID use; however, pregnancy is generally gastroprotective due to low gastric acid and high mucus.Epigastric pain and dyspepsia; may be underdiagnosed due to similarities with GERD.Urea breath test, serology, or endoscopic biopsy for H. pylori.H2 blockers, PPIs, or Sucralfate. Triple therapy (Amoxicillin/Metronidazole + Clarithromycin + PPI) for 14 days.
AchalasiaInflammatory destruction of the myenteric (Auerbach) plexus; the LES fails to relax during swallowing.Dysphagia, chest pain, and regurgitation.Barium swallow shows "bird beak" or "ace of spades" narrowing. Manometry is confirmatory.Soft diet, anticholinergics, nitrates, or botulinum toxin A. Myotomy is a last resort.
AppendicitisObstruction of the appendiceal lumen; the appendix moves upward and outward as the uterus enlarges.persistent abdominal pain; RLQ pain is most common, though pain may migrate higher in late pregnancy.MRI has the highest diagnostic yield in pregnancy. Clinically difficult due to pregnancy-related leukocytosis.Prompt surgical exploration; laparoscopy preferred in 1st/2nd trimester. Pre-op 2nd-gen cephalosporins.
Ulcerative Colitis (UC)Mucosal inflammation confined to the superficial luminal layers of the colon; begins at the rectum and is continuous.Diarrhea, rectal bleeding, tenesmus, and high risk for colon cancer (1%/year).Endoscopy shows granular, friable mucosa; (+) pANCA in 70% of cases.5-ASA (Mesalamine/Sulfasalazine). Methotrexate is strictly contraindicated (teratogenic).
Crohn DiseaseTransmural inflammation that can affect any part of the GI tract; characterized by patchy/segmental involvement.RLQ cramping, diarrhea, weight loss, and perianal fistulas/abscesses.Segmental colitis on endoscopy; (+) ASCA antibodies in 50% of cases.Similar to UC; surgery only for complications (obstruction/fistulas). Folic acid (4mg) recommended.
Intrahepatic Cholestasis (ICP)Genetic and hormonal factors; high estrogen impairs bile acid transport leading to bile salt retention.Intense pruritus (worse at night, involves palms/soles) in 2nd/3rd trimester; mild jaundice in 50%.Elevation of total serum bile acids (up to 100-fold).Ursodeoxycholic acid. Delivery at 38 weeks (mild) or 36 weeks (severe/jaundice).
Acute Fatty Liver of Pregnancy (AFLP)Mitochondrial abnormalities (LCHAD mutation) causing microvesicular fat accumulation in the liver.persistent nausea/vomiting, malaise, jaundice, and hypoglycemia in the 3rd trimester.Swansea Criteria (needs 6+ features). Biopsy unnecessary; ultrasound shows echogenic liver.Immediate delivery regardless of gestational age. Intensive supportive care.

GENERAL PRINCIPLES & PHYSIOLOGY

  • Progesterone in pregnancy causes decreased GI motility and decreased LES tone, which can lead to constipation and GERD.
  • Estrogen in pregnancy increases nausea and alters bile composition, predisposing the mother to gallstones.
  • hCG peaks in the 1st trimester and is the primary hormone linked to pregnancy-related vomiting.
  • Epigastric pain in the 3rd trimester is a "red flag" that requires checking blood pressure and liver enzymes to rule out preeclampsia/HELLP.
  • Alkaline phosphatase levels naturally rise 3-4 fold during normal pregnancy due to placental production, not liver damage.
  • AST, ALT, and Bilirubin levels do NOT change in a normal pregnancy; any elevation is considered pathologic.
  • Serum Albumin and total protein concentrations decrease during normal pregnancy due to hemodilution.
  • Gastrointestinal disorders in the Philippines are often complicated by high rates of anemia, malnutrition, and parasitic infections.

DIAGNOSTIC TECHNIQUES & NUTRITION

  • Upper GI endoscopy is considered safe for diagnosis and management during pregnancy when indicated.
  • Flexible sigmoidoscopy is the preferred method for visualizing the large bowel in pregnant women.
  • Polyethylene glycol is used for bowel prep; maternal dehydration must be avoided to maintain uteroplacental perfusion.
  • ERCP is useful for diagnosing and treating choledocholithiasis and pancreatic issues in pregnancy.
  • Abdominal sonography is the ideal first-line technique for GI imaging due to its lack of radiation.
  • Magnetic Resonance Imaging (MRI) is the preferred modality for viewing the retroperitoneal space and diagnosing appendicitis without radiation.
  • Laparoscopy is the preferred surgical approach in the 1st and 2nd trimesters; it carries a risk of preterm labor in the 3rd trimester.
  • Enteral nutrition (nasogastric tube) is always preferred over parenteral nutrition because it has fewer complications.
  • Central Parenteral Nutrition (CPN) is reserved for conditions like short bowel syndrome and requires central venous access for hyperosmolar solutions.

UPPER GI DISORDERS: KEY FACTS

  • Hyperemesis Gravidarum can cause Wernicke Encephalopathy due to thiamine deficiency, characterized by the triad of ocular signs, confusion, and ataxia.
  • Vitamin K deficiency in hyperemesis can lead to maternal coagulopathy and fetal intracranial hemorrhage.
  • Ondansetron (Zofran) should be reserved for cases after 8 weeks' gestation due to risks of prolonged QT interval and serotonin syndrome.
  • Boerhaave Syndrome is a serious esophageal rupture caused by sustained, forceful retching in hyperemesis.
  • Mallory-Weiss tears are small mucosal tears at the GE junction causing upper GI bleeding after persistent vomiting.
  • Diaphragmatic hernia repair is recommended during pregnancy, even if asymptomatic, because the maternal mortality rate of rupture is approximately 45%.
  • Vaginal delivery is generally contraindicated in unrepaired diaphragmatic hernias due to the risk of rupture from increased intraabdominal pressure.
  • Hiatal hernias are found in 20% of multiparas in late pregnancy and may cause vomiting or epigastric pain.

INTESTINAL & COLONIC DISORDERS: KEY FACTS

  • Acute diarrhea evaluation is required if it lasts >48 hours, involves fever >38°C, or grossly bloody stools.
  • Loperamide (Imodium) should be avoided in acute diarrhea if the etiology is unknown, as it may prolong the presence of toxins.
  • Clostridioides difficile is the most common nosocomial infection and is typically triggered by aminopenicillins or cephalosporins.
  • Fecal calprotectin is a valid inflammatory biomarker used to identify IBD flares in pregnant patients.
  • Toxic megacolon is a catastrophic complication of Ulcerative Colitis that may necessitate an emergency colectomy.
  • Bowel obstruction in pregnancy is most commonly caused by the growing uterus exerting pressure on pre-existing adhesions.
  • Tocolytics are not recommended for contractions following appendectomy due to the high risk of pulmonary edema in the setting of sepsis.

HEPATIC, BILIARY, & VIRAL DISORDERS: KEY FACTS

  • Acute Liver Failure in the non-pregnant population is most commonly caused by Acetaminophen toxicity.
  • Spider angiomata and palmar erythema occur in 2/3 of normal pregnancies due to high estrogen levels and are not necessarily signs of liver disease.
  • Intrahepatic Cholestasis of Pregnancy (ICP) increases the risk of fetal death if bile acid levels exceed 100 µmol/L due to cardiotoxicity.
  • Vaginal delivery is the preferred mode for liver failure patients to minimize incision-related bleeding, as the liver produces necessary coagulation factors.
  • Hepatitis B screening should be done for ALL pregnant women at the first visit; it is a DNA virus.
  • HBsAg is the first serologic marker to appear in an acute Hepatitis B infection.
  • Vertical transmission of Hep B is highest (90%) if the mother is HBeAg positive at delivery.
  • Neonatal intervention for Hep B involves giving the infant both HBIG and the Hep B vaccine series within 12 hours of birth.
  • Hepatitis C vertical transmission is low (<5%) but higher if the mother is coinfected with HIV.
  • Hepatitis A does NOT cause birth defects and maternal-fetal transmission has not been observed.
  • Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common chronic liver disease and is linked to obesity and metabolic syndrome.
  • Cholelithiasis (gallstones) is more common in pregnancy because gallbladder fasting and residual volumes double after the 1st trimester.
  • Bile sludge often regresses spontaneously after delivery.
  • Cholecystectomy is safe in all trimesters, but prophylactic removal of asymptomatic stones is NOT warranted.

DIFFERENTIAL COMPARISONS FOR EXAMS

  • Hyperemesis Gravidarum vs. Normal Morning Sickness: HG involves weight loss >5% and ketonuria; morning sickness typically resolves by 16 weeks and doesn't cause dehydration.
  • Acute Fatty Liver (AFLP) vs. HELLP Syndrome: AFLP is characterized by severe hypoglycemia and prolonged clotting times/hypofibrinogenemia; HELLP focus is on hemolysis and low platelets.
  • ICP vs. Viral Hepatitis: ICP presents with pruritus and high bile acids with minimal transaminase elevation; Hepatitis presents with malaise and very high transaminases (>1000 U/L).
  • Ulcerative Colitis vs. Crohn Disease: UC is continuous and involves only the mucosa/submucosa of the colon; Crohn's is patchy, transmural, and can affect the small bowel (distal ileum).
  • pANCA vs. ASCA: pANCA is associated with Ulcerative Colitis (70%); ASCA (Anti-S. cerevisiae) is associated with Crohn Disease (50%).
  • Boerhaave Syndrome vs. Mallory-Weiss Tear: Boerhaave is a full-thickness esophageal rupture (emergency); Mallory-Weiss reflects linear mucosal tears (usually self-limiting bleeding).
  • Epigastric Pain in 3rd Trimester: If BP is high, think Preeclampsia/HELLP; if BP is normal and patient has fatty food intolerance, think Cholecystitis.
  • Progesterone Effects vs. Mechanical Effects: Progesterone causes decreased LES tone (GERD) and slow GI transit; the enlarging uterus increases pressure on the stomach and displaces the appendix.
  • HBsAg vs. Anti-HBs: HBsAg indicates infection (active/carrier); Anti-HBs indicates immunity (previous infection or vaccination).
  • HBeAg vs. Anti-HBe: HBeAg indicates high viral replication and high infectivity; Anti-HBe suggests lower viral titers.
  • Enteral vs. Parenteral Nutrition: Enteral is via the GI tract (preferred); Parenteral is via the veins (used only if the GI tract must remain "quiescent").
  • PPN vs. CPN: PPN is short-term and peripheral; CPN is long-term, uses 24-40 kcal/kg/day, and requires high-flow central veins for hypertonic solutions.
  • Appendicitis Diagnosis: Ultrasound is first-line to rule out OB causes; MRI is the gold standard for definitive diagnosis in pregnancy.
  • Treatment of C. diff: Oral Vancomycin is 1st line; avoid Loperamide which can worsen the infection.
  • Hepatitis Transmission: Hep A is fecal-oral; Hep B and C are parenteral (blood/body fluids).
  • Management of Bile Stones: Symptomatic gallstones = Laparoscopic Cholecystectomy; Asymptomatic gallstones = Observation until postpartum.
  • Achalasia Appearance: Barium swallow shows a "bird beak" narrowing; GERD does not show this specific narrowing unless a stricture has formed.
  • Methotrexate: Excellent for ectopic pregnancy but strictly contraindicated for IBD management in a viable pregnancy due to teratogenicity.
  • Delivery in IBD: Vaginal delivery is the goal; Cesarean is only preferred if active perianal disease (fistulas/abscesses) is present in Crohn's.
  • Delivery in ICP: Routine induction at 38 weeks; if jaundice or bile acids are >100, deliver at 36 weeks.
  • Management of HG: Diclegis is the 1st step; if intractable, use IV fluids with Thiamine before any glucose-containing fluids to avoid Wernicke's.

QA

text

  1. What hormones contribute to the pathogenesis of Hyperemesis Gravidarum? | hCG, estrogen, progesterone
  2. Which bacterium is possibly linked to Hyperemesis Gravidarum? | Helicobacter pylori
  3. What is the weight loss criteria for Hyperemesis Gravidarum? | >5% weight loss
  4. Enumerate the metabolic/electrolyte imbalances in Hyperemesis Gravidarum (3). | Ketonuria, hypokalemia, alkalosis
  5. What is the first-line pharmacologic treatment for Hyperemesis Gravidarum? | Diclegis
    (Doxylamine + Pyridoxine)
  6. Which nutrient is given to prevent Wernicke Encephalopathy in Hyperemesis Gravidarum? | Thiamine (100mg)
  7. What is the primary pathogenesis of GERD in pregnancy? | Progesterone-induced LES relaxation
  8. What is the clinical term for heartburn often seen in GERD? | Pyrosis
  9. When does the prevalence of GERD symptoms typically increase? | 3rd trimester
  10. Which class of drugs is safe for GERD but must avoid Misoprostol? | PPIs and H2 blockers
  11. Why is pregnancy considered gastroprotective against Peptic Ulcer Disease? | Low gastric acid/High mucus
  12. List the components of Triple Therapy for H. pylori PUD (3). | Amoxicillin/Metronidazole,
    Clarithromycin,
    PPI
  13. Which plexus is destroyed in the pathogenesis of Achalasia? | Myenteric (Auerbach) plexus
  14. What classic finding is seen on a barium swallow for Achalasia? | "Bird beak" narrowing
  15. What is the confirmatory diagnostic test for Achalasia? | Manometry
  16. How does the position of the appendix change in Appendicitis during pregnancy? | Upward and outward
  17. What is the most common site of pain in Appendicitis, even in pregnancy? | Right Lower Quadrant (RLQ)
  18. What is the diagnostic modality of choice for Appendicitis in pregnancy? | MRI
  19. What is the preferred surgical approach for Appendicitis in the 1st/2nd trimester? | Laparoscopy
  20. Describe the extent of inflammation in Ulcerative Colitis. | Continuous, superficial mucosal inflammation
  21. Where does Ulcerative Colitis inflammation always begin? | Rectum
  22. Which serologic marker is found in 70% of Ulcerative Colitis cases? | pANCA
  23. What medication is strictly contraindicated in Ulcerative Colitis due to teratogenicity? | Methotrexate
  24. Describe the inflammatory pattern of Crohn Disease. | Transmural and patchy/segmental
  25. Which specific GI complications are characteristic of Crohn Disease? | Perianal fistulas/abscesses
  26. Which antibody is associated with 50% of Crohn Disease cases? | ASCA
  27. What is the folic acid recommendation for patients with Crohn Disease? | 4mg
  28. What causes Intrahepatic Cholestasis of Pregnancy (ICP)? | Impaired bile salt transport
  29. What is the hallmark clinical manifestation of ICP? | Pruritus (palms/soles)
  30. What lab result is diagnostic for ICP? | Elevated total serum bile acids
  31. What is the first-line medication for ICP? | Ursodeoxycholic acid
  32. When is delivery recommended for severe ICP or jaundice? | 36 weeks
  33. What mitochondrial abnormality is linked to Acute Fatty Liver of Pregnancy (AFLP)? | LCHAD mutation
  34. What metabolic emergency is a hallmark of AFLP? | Hypoglycemia
  35. Which criteria are used to diagnose AFLP? | Swansea Criteria
  36. What is the definitive management for AFLP? | Immediate delivery
  37. How does Progesterone affect GI motility in pregnancy? | Decreases motility
  38. How does Estrogen affect the gallbladder in pregnancy? | Predisposes to gallstones
  39. When does hCG peak in pregnancy? | 1st trimester
  40. Epigastric pain in the 3rd trimester is a "red flag" for which condition? | Preeclampsia/HELLP
  41. Which liver enzyme rises naturally in pregnancy due to placental production? | Alkaline phosphatase
  42. Which liver labs do NOT change in a normal pregnancy (3)? | AST, ALT, Bilirubin
  43. Why do serum albumin levels decrease during normal pregnancy? | Hemodilution
  44. Name three factors complicating Gastrointestinal disorders in the Philippines. | Anemia, malnutrition, parasitic infections
  45. Which diagnostic procedure is the preferred method for viewing the large bowel in pregnancy? | Flexible sigmoidoscopy
  46. Why must maternal dehydration be avoided during bowel prep with Polyethylene glycol? | Maintain uteroplacental perfusion
  47. What is ERCP used for in pregnancy? | Choledocholithiasis/Pancreatic issues
  48. What is the first-line imaging technique for GI issues in pregnancy? | Abdominal sonography
  49. Why is MRI preferred for diagnosing appendicitis in pregnancy? | No radiation/Good retroperitoneal view
  50. What is a risk of Laparoscopy performed in the 3rd trimester? | Preterm labor
  51. Why is Enteral nutrition preferred over parenteral nutrition? | Fewer complications
  52. Which condition specifically warrants Central Parenteral Nutrition (CPN)? | Short bowel syndrome
  53. What is the classic triad of Wernicke Encephalopathy? | Ocular signs, confusion, ataxia
  54. What are the neonatal risks of maternal Vitamin K deficiency? | Fetal intracranial hemorrhage
  55. Why is Ondansetron reserved until after 8 weeks' gestation? | QT interval/Serotonin syndrome risk
  56. Define Boerhaave Syndrome. | Full-thickness esophageal rupture
  57. Define Mallory-Weiss tears. | Mucosal GE junction tears
  58. What is the maternal mortality rate of a ruptured Diaphragmatic hernia? | Approximately 45%
  59. Why is vaginal delivery contraindicated in unrepaired Diaphragmatic hernias? | Risk of rupture
  60. What percentage of multiparas have Hiatal hernias in late pregnancy? | 20%
  61. When is evaluation for Acute diarrhea required? | Duration >48 hours/Fever/Bloody stools
  62. Why should Loperamide be avoided if the diarrhea etiology is unknown? | Prolongs toxin presence
  63. Which antibiotics typically trigger Clostridioides difficile? | Aminopenicillins or Cephalosporins
  64. What biomarker is used to identify IBD flares in pregnancy? | Fecal calprotectin
  65. What is Toxic megacolon? | Catastrophic UC complication
  66. What is the most common cause of Bowel obstruction in pregnancy? | Pressure on pre-existing adhesions
  67. Why are tocolytics avoided after an appendectomy in septic patients? | Risk of pulmonary edema
  68. What is the most common cause of Acute Liver Failure in the general population? | Acetaminophen toxicity
  69. What skin signs occur in 2/3 of pregnancies due to high estrogen? | Spider angiomata/Palmar erythema
  70. At what bile acid level does the risk of fetal death increase in ICP? | >100 µmol/L
  71. What is the preferred mode of delivery for Liver failure patients? | Vaginal delivery
  72. When should Hepatitis B screening be performed? | First prenatal visit
  73. Which serologic marker appears first in acute Hepatitis B? | HBsAg
  74. What HBeAg status in the mother correlates with 90% vertical transmission of Hep B? | HBeAg positive
  75. What two interventions are given to Hep B exposed neonates within 12 hours? | HBIG and Hep B vaccine
  76. What increases the risk of vertical transmission for Hepatitis C? | HIV coinfection
  77. Is Hepatitis A associated with birth defects? | No
  78. What is the most common chronic liver disease? | NAFLD
  79. How do gallbladder volumes change after the 1st trimester? | They double
  80. What is the management for Asymptomatic gallstones in pregnancy? | Observation/Expectant management
  81. Compare Hyperemesis Gravidarum vs. Morning Sickness regarding weight loss. | HG has >5% loss; Morning sickness does not.
  82. Compare AFLP vs. HELLP regarding glucose and coagulation. | AFLP: Hypoglycemia/Prolonged clotting
    HELLP: Hemolysis/Low platelets
  83. Compare ICP vs. Viral Hepatitis regarding transaminases. | ICP: Minimal elevation
    Hepatitis: Very high (>1000 U/L)
  84. Compare Ulcerative Colitis vs. Crohn Disease regarding thickness of inflammation. | UC: Mucosal/superficial
    Crohn's: Transmural
  85. Which antibody is for UC and which is for Crohn's? | pANCA (UC); ASCA (Crohn's)
  86. Compare Boerhaave vs. Mallory-Weiss severity. | Boerhaave: Rupture (Emergency)
    Mallory-Weiss: Tear (Self-limiting)
  87. Epigastric pain in 3rd trimester + High BP Suggests? | Preeclampsia/HELLP
  88. Epigastric pain in 3rd trimester + Normal BP + Fatty food intolerance suggests? | Cholecystitis
  89. Contrast HBsAg vs. Anti-HBs. | HBsAg: Infection
    Anti-HBs: Immunity
  90. Contrast HBeAg vs. Anti-HBe. | HBeAg: High infectivity
    Anti-HBe: Lower viral titers
  91. Contrast Enteral vs. Parenteral Nutrition route. | Enteral: GI tract
    Parenteral: Veins
  92. Contrast PPN vs. CPN duration and flow. | PPN: Short-term/Peripheral
    CPN: Long-term/Central/Hypertonic
  93. What is the first-line drug for C. diff? | Oral Vancomycin
  94. Contrast the transmission of Hep A vs. Hep B/C. | Hep A: Fecal-oral
    Hep B/C: Parenteral
  95. Contrast Achalasia vs. GERD on barium swallow. | Achalasia: Bird beak
    GERD: No narrowing
  96. When is Cesarean delivery preferred in Crohn Disease? | Active perianal disease
  97. What is the routine induction timing for ICP? | 38 weeks
  98. What must be given BEFORE glucose in intractable Hyperemesis Gravidarum? | Thiamine
  99. What are the clinical signs of Achalasia (3)? | Dysphagia, chest pain, regurgitation
  100. What is the pathogenesis of AFLP? | Microvesicular fat accumulation
  101. What is the "Gold Standard" for diagnosing Appendicitis in pregnancy? | MRI
  102. Which IBD type has a 1%/year risk for colon cancer? | Ulcerative Colitis
  103. What are the characteristics of NAFLD? | Obesity and metabolic syndrome

8.2 - Hematologic Disorders

Summary

text

PHYSIOLOGIC ADAPTATION IN PREGNANCY

FeaturePhysiologic Change in Pregnancy
PathogenesisPlasma volume expands by 40-50%, while red blood cell mass increases only by 15-25%, leading to hemodilution.
Clinical ManifestationsPhysiologic anemia occurs; whole blood viscosity decreases; maternal heart rate and stroke volume increase.
Laboratory FindingsHct decreases from ~38-45% to ~34% (singleton) or ~30% (multifetal); fibrinogen levels double by term.
Unique FindingsMaternal hepcidin is profoundly decreased to augment iron absorption and fetal transport.
  • (Maternal Physiology) Plasma volume expansion by 40-50% disproportionately exceeds the 15-25% increase in red cell mass, resulting in hemodilution and physiologic anemia.
  • (Maternal Physiology) Hematocrit levels typically decrease during pregnancy to an average of 34% in singleton pregnancies and 30% in multifetal gestations.
  • (Maternal Physiology) Oxygen-carrying capacity remains normal during pregnancy despite hemodilution and physiologic anemia.
  • (Maternal Physiology) Whole blood viscosity decreases during pregnancy due to the decline in hemoglobin and hematocrit concentrations.
  • (Maternal Physiology) Hemoglobin concentration at term is normally 12.5 g/dL; values below 11.0 g/dL are considered abnormal and usually signify iron deficiency.
  • (Maternal Physiology) Maternal blood volume expansion reaches a plateau during the last weeks of pregnancy after rising most rapidly during the midtrimester.
  • (Maternal Physiology) Iron requirements increase from 1 mg/day in non-pregnant women to approximately 7 mg/day in the third trimester to support the fetus, placenta, and expanded maternal red cell mass.
  • (Maternal Physiology) Total iron requirement for a healthy normal pregnancy is approximately 1000 mg, with 300 mg transferred to the fetus/placenta and 200 mg lost through normal excretion.
  • (Maternal Physiology) Maternal hepcidin levels are suppressed 10-fold in the second trimester compared to the first to facilitate greater iron absorption via ferroportin in enterocytes.
  • (Maternal Physiology) Coagulation factors VII, VIII, IX, and X increase during pregnancy, creating a physiologic hypercoagulable state to prevent hemorrhage.
  • (Maternal Physiology) Fibrinogen levels double by term (reaching up to 600+ mg/dL), while fibrinolysis is simultaneously inhibited.
  • (Maternal Physiology) Protein S functional activity significantly decreases during pregnancy (dropping from ~65-140% to ~16-42% by the 3rd trimester), contributing to the prothrombotic state.
  • (Maternal Physiology) Platelet counts decrease from the mid-second to third trimester due to dilution, increased spleen size (50% increase), and pooling in the intervillous space.
  • (Maternal Physiology) Left ventricular mass increases throughout pregnancy, beginning at 26 to 30 weeks' gestation.
  • (Maternal Physiology) Arterial blood pressure usually declines to a nadir at 24 to 26 weeks, with diastolic pressure decreasing more than systolic pressure.

ANEMIA: DIAGNOSIS AND GENERAL CAUSES

TypeDiagnostic Thresholds (CDC 1998)
1st TrimesterHemoglobin < 11.0 g/dL
2nd TrimesterHemoglobin < 10.5 g/dL
3rd TrimesterHemoglobin < 11.0 g/dL
  • (Anemia Diagnosis) Anemia is defined as a decreased blood concentration of hemoglobin, regardless of cause, morphology, or RBC function.
  • (Anemia Diagnosis) Anemia thresholds for pregnant women differ by trimester: <11 g/dL in the first/third and <10.5 g/dL in the second trimester according to the CDC.
  • (Anemia Diagnosis) Microcytic anemia evaluation requires measuring serum ferritin and performing hemoglobin electrophoresis to differentiate iron deficiency from hemoglobinopathies.
  • (Anemia Diagnosis) Macrocytic anemia evaluation primarily involves checking serum folate and vitamin B12 levels.
  • (Acute Blood Loss) Oral iron therapy can be provided for three months to a moderately anemic woman (Hgb ~7 g/dL) who is hemodynamically stable, able to ambulate, and not septic.
  • (Chronic Anemia) Anemia of chronic disease is characterized by slightly hypochromic/microcytic cells, low transferrin saturation, high serum ferritin, and elevated hepcidin which restricts iron export.
  • (Chronic Anemia) Recombinant erythropoietin is considered in pregnancies with chronic renal insufficiency when the hematocrit approximates 20 percent.

IRON DEFICIENCY ANEMIA (IDA)

CategoryFeatures of Iron Deficiency Anemia (IDA)
PathogenesisInsufficient iron to meet the ~1000 mg demand of pregnancy, fetal transfer, and red cell mass expansion.
DiagnosisMCV < 80 fL, Serum Ferritin ≤ 10–15 μg/L, Increased TIBC, Decreased Transferrin Saturation.
Treatment200 mg elemental iron/day (oral salts); IV iron (ferrous sucrose) if oral is not tolerated.
Unique FindingsMost common cause of anemia in pregnancy; fetal iron uptake is preserved even if the mother is severely anemic.
  • (Iron Deficiency Anemia) Iron deficiency anemia is the most common cause of anemia in pregnancy, resulting from an inability to meet the 1000 mg requirement.
  • (Iron Deficiency Anemia) Serum ferritin levels below 10–15 μg/L specifically confirm iron-deficiency anemia in gravidas.
  • (Iron Deficiency Anemia) Ferritin acts as an acute phase reactant, so levels up to 100 ng/mL may still be compatible with IDA in the presence of inflammation or infection.
  • (Iron Deficiency Anemia) Erythropoietin (EPO) synthesis increases in pregnancy due to hypoxia sensed by the kidneys, supporting RBC mass expansion.
  • (Iron Deficiency Anemia) Erythroferrone (ERFE) is upregulated by EPO to sequester hepcidin-inducer BMP6, thereby lowering hepcidin and increasing iron flow.
  • (Iron Deficiency Anemia) Red cell distribution width (RDW) is high in IDA, reflecting significant anisopoikilocytosis on a peripheral smear.
  • (Iron Deficiency Anemia) Bone marrow iron stores (absent) is the most sensitive and specific criterion for iron deficiency erythropoiesis, though bone marrow exam is rarely needed.
  • (Iron Deficiency Anemia) Maternal complications of IDA include increased risk of infections, preterm labor, PPROM, postpartum hemorrhage, and increased mortality.
  • (Iron Deficiency Anemia) Fetal complications of maternal IDA include low birth weight (LBW), IUGR, and impaired long-term neurodevelopment.
  • (Iron Deficiency Anemia) Hydrops fetalis or intrauterine death can result from severe fetal anemia leading to high-output heart failure.

MEGALOBLASTIC AND APLASTIC ANEMIA

FeatureMegaloblastic AnemiaAplastic Anemia
PathogenesisImpaired DNA synthesis due to Folate or B12 deficiency; asynchronous maturation.Marked decline in committed marrow stem cells; pancytopenia.
Unique FindingsMegaloblasts (large nucleated RBCs) in marrow; hypersegmented neutrophils.Rare in pregnancy; may improve/remit after delivery if pregnancy-induced.
Management5-15 mg oral folic acid with iron; nutritious diet.Immunosuppression, prompt antimicrobials, bone marrow transplant.
  • (Megaloblastic Anemia) Folate deficiency is essential for DNA synthesis; deficiency is common in poor nutritional states or users of anticonvulsants.
  • (Megaloblastic Anemia) Vitamin B12 deficiency is typically seen in vegetarians, vegans, or patients with malabsorption/GI surgery.
  • (Megaloblastic Anemia) Megaloblasts are large RBC precursors caused by impaired nuclear division with relatively normal cytoplasmic maturation (asynchronous maturation).
  • (Aplastic Anemia) Aplastic anemia is a grave complication characterized by pancytopenia and a markedly hypocellular bone marrow.
  • (Aplastic Anemia) Diamond-Blackfan anemia is a pure red cell hypoplasia that responds well to glucocorticoid therapy but increases risk of preeclampsia and FGR.
  • (Aplastic Anemia) Gaucher disease is an autosomal recessive lysosomal deficiency of acid β-glucosidase that causes anemia and thrombocytopenia worsening in pregnancy.
  • (Aplastic Anemia) Red cell transfusions in aplastic anemia are indicated to maintain a hematocrit above 20 percent.

HEMOLYTIC ANEMIA AND HEMOGLOBINOPATHIES

DiseasePathogenesisDiagnostic Finding
Autoimmune HemolysisWarm-active or cold-active autoantibodies against RBCs.Positive Direct and Indirect Coombs tests.
Paroxysmal Nocturnal Hemoglobinuria (PNH)X-linked PIG-A gene mutation; complement-mediated lysis.Intermittent hemoglobinuria; thrombosis risk (40%).
Hereditary SpherocytosisMutations in spectrin/ankyrin destabilize lipid bilayer.Spherocytes; increased osmotic fragility.
Sickle Cell (Hb SS)Beta-globin glutamic acid → valine substitution.Sickled cells; Hb electrophoresis showing HbS.
ThalassemiaReduced synthesis of alpha or beta globin chains.Hb Bart (Alpha major); High HbA2 (Beta minor).
  • (Hemolytic Anemia) Evans syndrome refers to autoimmune hemolysis comorbid with thrombocytopenia.
  • (Hemolytic Anemia) Paroxysmal Nocturnal Hemoglobinuria (PNH) carries a high risk of venous thromboembolism (40% of cases) and is treated with eculizumab.
  • (Hemolytic Anemia) G6PD deficiency leads to episodic anemia triggered by drugs (e.g., Macrodantin) or infections; it is an X-linked recessive disorder.
  • (Hemoglobinopathies) Sickle-cell crisis is a diagnosis of exclusion in pregnancy and is managed with IV fluids, prompt opioid analgesia, and oxygen.
  • (Hemoglobinopathies) Acute chest syndrome in sickle cell patients presents with pleuritic chest pain, fever, and new lung infiltrates; it occurs in ~6% of pregnant women.
  • (Hemoglobinopathies) Sickle-cell trait (Hb AS) occurs in ~8% of African Americans and is NOT a deterrent to pregnancy but increases risk for asymptomatic bacteriuria.
  • (Hemoglobinopathies) Hemoglobin E is common in Southeast Asia; homozygous state (Hb EE) shows marked microcytosis but little anemia.
  • (Thalassemia) Alpha-thalassemia major (Hb Bart disease) involves deletion of all 4 alpha genes and is incompatible with survival, often resulting in hydrops fetalis.
  • (Thalassemia) Beta-thalassemia minor is characterized by elevated Hemoglobin A2 (>3.5%) and mild hypochromic microcytic anemia.
  • (Polycythemia) Polycythemia vera is a myeloproliferative neoplasm associated with the JAK2 mutation and requires aggressive management with aspirin and LMWH.

PLATELET AND MICROANGIOPATHIC DISORDERS

DisorderPrimary MechanismHallmark Lab Finding
Gestational ThrombocytopeniaHemodilution and splenic pooling.Plt > 70k (75% of pregnancy cases).
TTPADAMTS13 deficiency (Inhibitory IgG).ADAMTS13 activity < 10%.
HELLPSpiral artery remodeling defects → systemic inflammation.High AST/ALT; LDH > 600.
CM-TMA (aHUS)Complement gene mutations (Auto-FH antibodies).Complement dysregulation; high MAC.
  • (Platelet Disorders) Gestational thrombocytopenia accounts for 75% of thrombocytopenia cases in pregnancy and usually requires no treatment.
  • (Thrombotic Microangiopathy) Thrombotic microangiopathy (TMA) is characterized by microangiopathic hemolytic anemia (MAHA), schizocytes on smear, and end-organ damage.
  • (TTP) Thrombotic thrombocytopenic purpura (TTP) is confirmed by an ADAMTS13 activity level <10% and is treated primarily with plasmapheresis.
  • (TTP) TTP clinical pentad includes thrombocytopenia, hemolytic anemia, fever, neurologic manifestations, and renal injury.
  • (HELLP vs TTP) HELLP syndrome is reversed by delivery, whereas delivery does NOT improve thrombotic microangiopathies like TTP.
  • (TMA treatment) Eculizumab is the preferred treatment for complement-mediated TMA (aHUS) and PNH.

INHERITED COAGULATION DEFECTS

  • (Hemophilia) Hemophilia A and B are X-linked recessive conditions; female carriers usually have ~50% factor activity due to lyonization but can experience bleeding if levels are <20%.
  • (Hemophilia) Desmopressin can be used to stimulate factor VIII release in patients with Hemophilia A.
  • (von Willebrand Disease) von Willebrand disease (VWD) is the most common inherited bleeding disorder; Type 1 is a partial quantitative deficiency, while Type 3 is a complete deficiency.
  • (von Willebrand Disease) VWF levels rise appreciably during normal pregnancy for Type 1, but women with Type 2 or 3 remain at high risk for postpartum hemorrhage (PPH).
  • (Thrombophilia) Inherited thrombophilias (e.g., Factor V Leiden, Prothrombin G20210A) increase the risk of venous thromboembolism (VTE) in pregnancy.
  • (Thrombophilia) Antithrombin deficiency is considered a high-risk inherited thrombophilia requiring management during pregnancy.

PHILIPPINE CONTEXT AND PUBLIC HEALTH

  • (Philippine Health Sector) 8-Point Action Agenda (2023-2028) aims to ensure every Filipino experiences health and well-being through humanistic leadership and good governance.
  • (Philippine Diet) Rice dependence and lack of dietary diversity contribute significantly to widespread iron and zinc deficiencies among Filipinos.
  • (Public Health Strategy) Biofortification is an effective approach to enrich rice with micronutrients to target vulnerable populations in the Philippines.
  • (Hemophilia in PH) Hemophilia prevalence in the Philippines may be 10 times higher than the 1604 cases currently diagnosed based on worldwide estimates.

HIGH-YIELD DIFFERENTIATION AND COMPARISON

  • (Comparison: Physiologic vs. Pathologic) Physiologic anemia results from expanded plasma volume (40-50%) exceeding RBC mass increase (20%), whereas iron deficiency anemia is confirmed when Hgb falls below 11 g/dL.
  • (Comparison: Sickle Cell SS vs. SC) Hb SS disease has significantly higher maternal mortality (OR 11-23) compared to Hb SC disease, though both increase stillbirth risk.
  • (Comparison: TTP vs. HELLP) Transaminitis (High AST/ALT) is characteristic of HELLP syndrome, whereas it is usually absent or mild in TTP.
  • (Comparison: TTP vs. HELLP) ADAMTS13 deficiency (&lt10%) is the hallmark of TTP, while it is only mild-to-moderately reduced in HELLP.
  • (Comparison: Delivery effect) Delivery reverses the pathology of HELLP and Preeclampsia, but has no effect on the progression of TMA/TTP.
  • (Comparison: Thalassemia Types) Alpha-thalassemia is more common in Asian Americans, while Beta-thalassemia is diagnosed by elevated HbA2 levels.
  • (Comparison: Hemophilia vs. vWD) Hemophilia is X-linked (mostly males affected), whereas von Willebrand disease is autosomal (affects males and females equally).
  • (Comparison: Thalassemia major vs. trait) Alpha-thalassemia major (Hb Bart) leads to hydrops fetalis and stillbirth, while Alpha-thalassemia trait (2 gene deletion) presents as mild microcytic anemia with no major maternal issues.
  • (Comparison: Ferritin) Low ferritin (&lt15) is specific for IDA, but Ferritin can be falsely elevated up to 100 in patients with IDA who also have liver disease or infection.
  • (Comparison: Thrombophilia risk) Heterozygous Factor V Leiden is a low-risk thrombophilia, while Homozygous Factor V Leiden is a high-risk condition.
  • (Comparison: Relative vs. Absolute Polycythemia) Relative polycythemia is caused by volume loss (dehydration/diuretics), while Absolute polycythemia (Polycythemia Vera) involves a JAK2 mutation and increased RBC mass.
  • (Comparison: B12 vs. Folate) B12 deficiency is common in vegans/gastric surgery; Folate deficiency is common in malnutrition or anticonvulsant use.
  • (Comparison: Spherocytosis vs. G6PD) Hereditary spherocytosis shows increased osmotic fragility; G6PD deficiency shows episodic hemolysis after oxidant triggers (drugs/infection).
  • (Comparison: Hemophilia A vs. B) Hemophilia A is a deficiency of Factor VIII; Hemophilia B (Christmas Disease) is a deficiency of Factor IX.
  • (Comparison: Schizocytes) Schizocytes are present in all TMAs (TTP, HUS, HELLP), but the severity of fragmentation is most marked in TTP.

QA

text

PHYSIOLOGIC ADAPTATION IN PREGNANCY

  1. Under Physiologic Adaptation, what is the pathogenesis of hemodilution? | Plasma volume expansion (40-50%) exceeds red blood cell mass increase (15-25%).
  2. What are the clinical manifestations (3) of Physiologic Adaptation? | 1) Physiologic anemia
    2) Decreased blood viscosity
    3) Increased heart rate/stroke volume
  3. What are the laboratory findings (2) for Physiologic Adaptation hematocrit? | 1) ~34% (singleton)
    2) ~30% (multifetal)
  4. What happens to Maternal hepcidin to augment iron absorption? | Profoundly decreased.
  5. Why does Plasma volume expansion result in physiologic anemia? | It disproportionately exceeds red cell mass increase.
  6. What is the typical Hematocrit level in a singleton pregnancy? | 34 percent.
  7. What is the typical Hematocrit level in a multifetal gestation? | 30 percent.
  8. How is Oxygen-carrying capacity affected by physiologic anemia? | Remains normal.
  9. Why does Whole blood viscosity decrease during pregnancy? | Decline in hemoglobin and hematocrit.
  10. What Hemoglobin concentration at term is considered abnormal/iron deficient? | Values below 11.0 g/dL.
  11. When does Maternal blood volume expansion reach a plateau? | Last weeks of pregnancy.
  12. What are the Iron requirements in the third trimester? | 7 mg/day. (Compared to 1 mg/day in non-pregnant).
  13. What is the Total iron requirement for a healthy normal pregnancy? | Approximately 1000 mg.
  14. How much total iron is transferred to the Fetus/Placenta? | 300 mg.
  15. By how much is Maternal hepcidin suppressed to facilitate iron absorption? | 10-fold (in second trimester).
  16. Which Coagulation factors (4) increase creating a hypercoagulable state? | Factors VII, VIII, IX, and X.
  17. What happens to Fibrinogen levels by term? | They double (up to 600+ mg/dL).
  18. What happens to Protein S functional activity in the 3rd trimester? | Significantly decreases (to ~16-42%).
  19. What are the causes (3) of decreased Platelet counts in pregnancy? | 1) Dilution
    2) Splenic pooling
    3) Pooling in intervillous space.
  20. When does Left ventricular mass begin to increase? | 26 to 30 weeks' gestation.
  21. When does Arterial blood pressure reach its nadir? | 24 to 26 weeks.

ANEMIA: DIAGNOSIS AND GENERAL CAUSES

  1. What is the Hemoglobin threshold for anemia in the 1st trimester? | < 11.0 g/dL.
  2. What is the Hemoglobin threshold for anemia in the 2nd trimester? | < 10.5 g/dL.
  3. What is the Hemoglobin threshold for anemia in the 3rd trimester? | < 11.0 g/dL.
  4. How is Anemia broadly defined? | Decreased blood hemoglobin concentration.
  5. What tests (2) are required for Microcytic anemia evaluation? | 1) Serum ferritin
    2) Hemoglobin electrophoresis.
  6. What levels (2) are checked for Macrocytic anemia evaluation? | 1) Serum folate
    2) Vitamin B12.
  7. When is Oral iron therapy indicated for moderate anemia (Hgb ~7 g/dL)? | Hemodynamically stable, ambulating, and non-septic.
  8. What are the laboratory characteristics (4) of Anemia of chronic disease? | 1) High ferritin
    2) Elevated hepcidin
    3) Hypochromic/microcytic
    4) Low transferrin saturation.
  9. When is Recombinant erythropoietin considered in renal insufficiency? | Hematocrit approximates 20 percent.

IRON DEFICIENCY ANEMIA (IDA)

  1. What is the pathogenesis of Iron Deficiency Anemia (IDA)? | Insufficient iron to meet 1000 mg demand.
  2. What are the diagnostic findings (4) for Iron Deficiency Anemia (IDA)? | 1) MCV < 80 fL
    2) Ferritin ≤ 10–15 μg/L
    3) Increased TIBC
    4) Decreased Transferrin Sat.
  3. What is the oral treatment dose for Iron Deficiency Anemia (IDA)? | 200 mg elemental iron/day.
  4. What is the Most common cause of anemia in pregnancy? | Iron deficiency anemia.
  5. What Serum ferritin level specifically confirms iron-deficiency? | Below 10–15 μg/L.
  6. Why might Ferritin be as high as 100 ng/mL in IDA? | It acts as an acute phase reactant.
  7. Why does Erythropoietin (EPO) synthesis increase in pregnancy? | Renal hypoxia.
  8. What is the role of Erythroferrone (ERFE) in iron metabolism? | Lowers hepcidin (via BMP6 sequestration).
  9. What does a high Red cell distribution width (RDW) reflect in IDA? | Anisopoikilocytosis.
  10. What is the most sensitive/specific criterion for Iron deficiency erythropoiesis? | Absent bone marrow iron stores.
  11. What are the maternal complications (5) of Iron Deficiency Anemia? | 1) Infections
    2) Preterm labor
    3) PPROM
    4) Postpartum hemorrhage
    5) Increased mortality.
  12. What are the fetal complications (3) of Maternal Iron Deficiency Anemia? | 1) Low birth weight
    2) IUGR
    3) Impaired long-term neurodevelopment.
  13. What is the result of severe fetal anemia on the Fetal heart? | High-output heart failure (Hydrops).

MEGALOBLASTIC AND APLASTIC ANEMIA

  1. What is the pathogenesis of Megaloblastic Anemia? | Impaired DNA synthesis (Folate/B12 deficiency).
  2. What are the hallmark findings (2) of Megaloblastic Anemia? | 1) Megaloblasts in marrow
    2) Hypersegmented neutrophils.
  3. What is the treatment for Megaloblastic Anemia? | 5-15 mg oral folic acid with iron.
  4. What is the pathogenesis of Aplastic Anemia? | Decline in committed marrow stem cells.
  5. What is the clinical hallmark of Aplastic Anemia? | Pancytopenia.
  6. What is the management (3) for Aplastic Anemia? | 1) Immunosuppression
    2) Antimicrobials
    3) Bone marrow transplant.
  7. Which vitamin deficiency is common in users of Anticonvulsants? | Folate deficiency.
  8. Which population is typically affected by Vitamin B12 deficiency? | Vegetarians/Vegans or malabsorption patients.
  9. How are Megaloblasts formed? | Impaired nuclear division with normal cytoplasm maturation.
  10. What marrow finding characterizes Aplastic anemia? | Markedly hypocellular bone marrow.
  11. What are the pregnancy risks associated with Diamond-Blackfan anemia? | Preeclampsia and Fetal Growth Restriction.
  12. What is the enzyme deficiency in Gaucher disease? | Acid β-glucosidase.
  13. What is the target hematocrit for Red cell transfusions in aplastic anemia? | Above 20 percent.

HEMOLYTIC ANEMIA AND HEMOGLOBINOPATHIES

  1. What is the diagnostic finding for Autoimmune Hemolysis? | Positive Direct and Indirect Coombs tests.
  2. What is the mutation and risk in Paroxysmal Nocturnal Hemoglobinuria (PNH)? | 1) PIG-A mutation
    2) 40% Thrombosis risk.
  3. What is the hallmark lab finding for Hereditary Spherocytosis? | Increased osmotic fragility.
  4. What is the protein substitution in Sickle Cell (Hb SS)? | Beta-globin glutamic acid to valine.
  5. What hemoglobin markers (2) define Thalassemia types? | 1) Hb Bart (Alpha major)
    2) High HbA2 (Beta minor).
  6. What is Evans syndrome? | Autoimmune hemolysis with thrombocytopenia.
  7. What drug is used to treat Paroxysmal Nocturnal Hemoglobinuria (PNH)? | Eculizumab.
  8. What triggers episodic anemia in G6PD deficiency? | Drugs (e.g., Macrodantin) or infections.
  9. What is the management (3) for Sickle-cell crisis in pregnancy? | 1) IV fluids
    2) Opioid analgesia
    3) Oxygen.
  10. What are the symptoms (3) of Acute chest syndrome? | 1) Pleuritic chest pain
    2) Fever
    3) New lung infiltrates.
  11. What is the primary risk of Sickle-cell trait (Hb AS) in pregnancy? | Asymptomatic bacteriuria.
  12. What is the state of anemia in Hemoglobin E homozygotes (Hb EE)? | Marked microcytosis but little anemia.
  13. What is the outcome of Alpha-thalassemia major (Hb Bart disease)? | Incompatible with survival (hydrops fetalis).
  14. What Hemoglobin A2 level indicates Beta-thalassemia minor? | Greater than 3.5%.
  15. What mutation is associated with Polycythemia vera? | JAK2 mutation.

PLATELET AND MICROANGIOPATHIC DISORDERS

  1. What is the hallmark of Gestational Thrombocytopenia? | Platelets > 70,000.
  2. What deficiency confirms Thrombotic thrombocytopenic purpura (TTP)? | ADAMTS13 activity < 10%.
  3. What are the laboratory hallmarks (2) of HELLP? | 1) High AST/ALT
    2) LDH > 600.
  4. What causes Complement-mediated TMA (aHUS)? | Complement gene mutations (Auto-FH antibodies).
  5. What percentage of pregnancy thrombocytopenia is Gestational thrombocytopenia? | 75 percent.
  6. What are the general features (3) of Thrombotic microangiopathy (TMA)? | 1) MAHA
    2) Schizocytes
    3) End-organ damage.
  7. What is the primary treatment for Thrombotic thrombocytopenic purpura (TTP)? | Plasmapheresis.
  8. Name the components of the TTP clinical pentad (5). | 1) Thrombocytopenia 2) Hemolytic anemia 3) Fever 4) Neuro symptoms 5) Renal injury.
  9. Does delivery improve Thrombotic thrombocytopenic purpura (TTP)? | No. (Delivery reverses HELLP).
  10. What is the preferred treatment for aHUS and PNH? | Eculizumab.

INHERITED COAGULATION DEFECTS

  1. Why can female carriers of Hemophilia A and B experience bleeding? | Factor levels <20% (due to lyonization).
  2. What drug stimulates Factor VIII release in Hemophilia A? | Desmopressin.
  3. Compare von Willebrand Disease Type 1 vs Type 3. | Type 1: Partial quantitative deficiency
    Type 3: Complete deficiency.
  4. Which von Willebrand Disease types have high risk for postpartum hemorrhage? | Type 2 or 3.
  5. Give examples (2) of Inherited thrombophilias that increase VTE risk. | 1) Factor V Leiden
    2) Prothrombin G20210A.
  6. Why is Antithrombin deficiency significant in pregnancy? | It is a high-risk inherited thrombophilia.

PHILIPPINE CONTEXT AND PUBLIC HEALTH

  1. What is the goal of the 8-Point Action Agenda (2023-2028)? | Ensure every Filipino health and well-being.
  2. How does the Philippine Diet contribute to iron/zinc deficiency? | Rice dependence and lack of diversity.
  3. What is Biofortification? | Enriching rice with micronutrients for vulnerable populations.
  4. How does actual Hemophilia prevalence in PH compare to diagnosed cases? | May be 10 times higher than diagnosed.

HIGH-YIELD DIFFERENTIATION AND COMPARISON

  1. Contrast Physiologic vs Iron Deficiency Anemia. | Physiologic: Hemodilution
    IDA: Hgb < 11 g/dL with iron lack.
  2. Compare Hb SS vs Hb SC disease mortality. | Hb SS: Significantly higher maternal mortality (OR 11-23).
  3. Compare TTP vs HELLP liver enzymes. | HELLP: Transaminitis (High AST/ALT)
    TTP: Absent/mild.
  4. Compare TTP vs HELLP ADAMTS13 activity. | TTP: <10% activity
    HELLP: Mildly reduced.
  5. How does Delivery affect HELLP vs TTP? | Delivery reverses HELLP but has no effect on TTP.
  6. How is Beta-thalassemia diagnosed? | Elevated HbA2 levels.
  7. Contrast the inheritance of Hemophilia vs von Willebrand Disease. | Hemophilia: X-linked
    vWD: Autosomal.
  8. Contrast Alpha-thalassemia major vs trait. | Major: Hydrops fetalis
    Trait: Mild microcytic anemia.
  9. When can Ferritin be falsely elevated in IDA? | Liver disease or infection (up to 100 ng/mL).
  10. Compare Heterozygous vs Homozygous Factor V Leiden risk. | Heterozygous: Low-risk
    Homozygous: High-risk.
  11. Contrast Relative vs Absolute Polycythemia. | Relative: Volume loss
    Absolute: JAK2 mutation/increased RBC mass.
  12. Contrast the causes of B12 vs Folate deficiency. | B12: Vegan/Gastric surgery
    Folate: Malnutrition/Anticonvulsants.
  13. Contrast Spherocytosis vs G6PD deficiency labs. | Spherocytosis: Osmotic fragility
    G6PD: Episodic (oxidant triggered).
  14. Contrast Hemophilia A vs B factor deficiency. | A: Factor VIII
    B: Factor IX.
  15. In which condition is Schizocyte fragmentation most marked? | Thrombotic thrombocytopenic purpura (TTP).

8.3 - DM in Pregnancy

Summary

text

DIABETES MELLITUS IN PREGNANCY: OVERVIEW AND COMPARISON

FeatureType 1 DiabetesType 2 DiabetesGestational Diabetes (GDM)Overt Diabetes
PathogenesisPancreatic $\beta$-cell destruction leading to absolute insulin deficiency.Ranges from insulin resistance to insulin secretory defect with resistance.Pregnancy-induced insulin resistance with inadequate $\beta$-cell compensation.Likely pre-existing Type 2 DM undocumented before pregnancy.
OnsetUsually clinically apparent before age 30.Often related to lifestyle, obesity, and heredofamilial factors.Onset or first recognition during pregnancy, typically 24-28 weeks.Discovered for the 1st time during pregnancy, usually in the 1st trimester.
Typical ScreeningIdentified before reproductive age.Identified before or early in pregnancy.Universal screening at 24-28 weeks (or earlier if high risk).Screened at first prenatal visit via FBS.
Diagnosis CriteriaStandard non-pregnant criteria.Standard non-pregnant criteria.75-g OGTT: FBS $\geq$ 92, 1h $\geq$ 180, or 2h $\geq$ 153 (IADPSG).FBS $\geq$ 126 mg/dL OR HbA1c $\geq$ 6.5% OR RPG $\geq$ 200 mg/dL.
ManagementInsulin always required.MNT, then oral agents or insulin.MNT trial for 2 weeks; Insulin if uncontrolled.Immediate pharmacological management (Insulin/Metformin).

EPIDEMIOLOGY AND RISK FACTORS

  • Filipino women are considered a high-risk ethnic group for hyperglycemia in pregnancy, with an estimated prevalence of 6-20% in the Philippines.
  • Southeast Asian race is a significant risk factor as this population has the highest global risk for hyperglycemia.
  • History of Macrosomia (defined as a birthweight of $\geq$ 9 lbs or 4 kg) is a major risk factor for Gestational Diabetes Mellitus and may indicate undiagnosed GDM in previous pregnancies.
  • Advanced Maternal Age (e.g., 36 years old) increases the risk of developing glucose intolerance during pregnancy.
  • Obesity (BMI $\geq$ 30 or BMI $\geq$ 25 in Asians) contributes to GDM through central adiposity and the release of leptin and proinflammatory cytokines.
  • Polycystic Ovary Syndrome (PCOS) is a pertinent risk factor for GDM due to its underlying insulin resistance.
  • History of unexplained stillbirths or abortions is a clinical indicator for screening, as increased sugar can cause a lack of oxygen and sudden cessation of the fetal heartbeat.
  • Persistent glycosuria (measured as +3 or +4 glucose in urine) warrants immediate investigation for diabetes in pregnancy.
  • Strong family history of diabetes is a critical factor; if a direct relative has DM, the chance of the patient developing it is significantly high.

MATERNAL AND FETAL PATHOPHYSIOLOGY

  • Pregnancy-related hormones (Progesterone, Placentally derived Growth Hormone, Prolactin, Cortisol) are elevated in the 2nd trimester and naturally increase insulin resistance to maintain fetal growth.
  • Maternal metabolic adaptations to pregnancy include fasting hypoglycemia, postprandial hyperglycemia, and hyperinsulinemia.
  • Proinflammatory cytokines (TNF-alpha, IL-6, IGF-1) evoke insulin resistance during pregnancy, contributing to the pathogenesis of GDM.
  • Maternal hyperglycemia leads to the transfer of excess glucose to the fetus, which stimulates the fetal pancreas to secrete its own insulin.
  • Fetal hyperinsulinemia acts as a growth hormone, promoting fat deposition and excessive anabolism, leading to Fetal Macrosomia.
  • Aerobic metabolism of glucose consumes oxygen; extreme maternal hyperglycemia can lead to fetal hypoxemia because the baby uses excessive oxygen to process high glucose levels.
  • Placental development is usually fully established by the 24-28th week, which is why screening is most effective at this interval to detect placentally-derived glucose elevation.

SCREENING AND DIAGNOSTIC CRITERIA (IADPSG)

  • Universal screening for GDM is recommended for all pregnant women, regardless of risk, because the Filipino race itself is a high-risk factor.
  • First prenatal visit screening aims to categorize patients: FBS $\leq$ 92 mg% is normal, 92-125 mg% is GDM, and $\geq$ 126 mg% is overt DM.
  • Low-risk patients should undergo a 75-g OGTT at 24-28 weeks gestation.
  • High-risk patients (obese, family history) should receive an immediate 75-g OGTT at the first visit, even if the initial FBS is normal.
  • 75-g OGTT Procedure (IADPSG) requires 6-8 hours of fasting, blood collection at baseline, 1 hour, and 2 hours after drinking the glucose solution.
  • IADPSG Diagnostic Thresholds for GDM (75-g OGTT) require only ONE value to be met or exceeded:
    1. Fasting Blood Sugar (FBS) $\geq$ 92 mg/dL
    2. 1-hour postprandial $\geq$ 180 mg/dL
    3. 2-hour postprandial $\geq$ 153 mg/dL
  • Overt Diabetes in pregnancy is diagnosed if any of the following are met: FBS $\geq$ 126 mg/dL, HbA1c $\geq$ 6.5%, or Random Plasma Glucose $\geq$ 200 mg/dL.
  • 75-g OGTT at 32 weeks should be repeated if signs of DM appear, such as polyhydramnios, macrosomia, polyphagia, polydipsia, or polyuria.

MANAGEMENT AND GLYCOSE TARGETS

  • Medical Nutrition Therapy (MNT) is the first-line management for 2 weeks; it was formerly known as Diet Restriction Management.
  • Pinggang Pinoy and small, frequent meals are encouraged to decrease the incidence of glucose spikes.
  • MNT Dietary Composition (ACOG) suggests 33–40% carbohydrates, ~20% protein, and ~40% fat. Note that low carbohydrate intake may lead to IUGR.
  • Insulin is the "Gold Standard" for pharmacological management and is initiated if target glucose levels are not achieved through MNT and exercise.
  • Insulin safety in pregnancy is high because it does NOT cross the placenta.
  • Self-Monitored Capillary Blood Glucose (CBG) Targets:
    • Fasting $\leq$ 95 mg/dL
    • 1-hour postprandial $\leq$ 140 mg/dL
    • 2-hour postprandial $\leq$ 120 mg/dL
  • Metformin is considered a second-line option for pharmacological management in selected cases.
  • Folic Acid supplementation should be 5 mg/day (lecturer) or 400 $\mu$g/day (book) given periconceptionally to reduce the risk of neural tube defects.
  • Weight Gain Guidelines are based on BMI: Obese (BMI $\ge$ 30) should only gain 5-9 kg total (0.21 kg/week in 2nd/3rd trimesters).

ANTENATAL SURVEILLANCE AND COMPLICATIONS

  • Congenital Heart Defects are the most common congenital anomaly affected by high maternal blood sugar before conception.
  • Congenital Anomaly Scan (CAS) with fetal ECHO is specifically indicated at 20-24 weeks for diabetic pregnancies to monitor for cardiac and CNS anomalies.
  • Fetal Kick Counting should begin at 26-28 weeks every night; a normal count is 10 movements in 2 hours.
  • Biophysical Profile (BPS) should be performed every 2 weeks starting at 28-37 weeks, increasing to twice a week if the patient is on insulin.
  • Aspirin (60-150 mg/day) is given from 12-16 weeks until delivery as prophylaxis for preeclampsia.
  • Shoulder Dystocia and birth trauma (e.g., Clavicular fracture) are major labor complications due to fetal macrosomia and enlargement of the fetal trunk.
  • Respiratory Distress Syndrome (RDS) in neonates occurs because elevated sugar levels delay the formation of lung surfactant.
  • Neonatal metabolic complications include hypoglycemia, hypocalcemia, and hypomagnesemia.
  • Neonatal polycythemia (increased hematocrit) is caused by hyperglycemia-induced increases in blood cell formation.
  • Hydramnios / Polyhydramnios is caused by hyperglycemia increasing osmolality, which leads to a transfer of fluids and increased amniotic fluid.

DELIVERY AND POSTNATAL CARE

  • Timing of delivery for well-controlled GDM is usually planned at 39 to 39 6/7 weeks.
  • Timing of delivery for insulin-treated GDM is recommended at 38-39 weeks.
  • Poorly controlled GDM requires earlier delivery at 37-38 weeks.
  • Elective Cesarean Section should be considered if the estimated fetal weight is $\geq$ 4500 g to prevent brachial plexus injury.
  • Postpartum glucose metabolism assessment involves a repeat 75-g, 2-hr OGTT at 6-12 weeks after delivery.
  • Postpartum classification uses non-pregnant thresholds: DM if FBS $\geq$ 126 mg/dL or 2-hr $\geq$ 200 mg/dL.
  • GDM recurrence risk is significant, with a 50-75% likelihood of developing Type 2 DM within 15-25 years.

DIFFERENTIATING SIMILAR ENTITIES IN EXAMS

  1. GDM vs. Overt DM (AOG): GDM is recognized later in pregnancy (typically after 20 weeks/2nd trimester), while Overt DM is discovered in the 1st trimester (before 20 weeks).
  2. GDM vs. Overt DM (FBS criteria): Overt DM requires an FBS $\geq$ 126 mg/dL; GDM is diagnosed with an FBS between 92-125 mg/dL.
  3. IADPSG vs. ADA Screening: IADPSG requires only ONE abnormal value on the 75-g OGTT, whereas ADA criteria traditionally require TWO abnormal values.
  4. GDM FBS vs. Non-pregnant FBS: The cutoff for fasting glucose in pregnancy is lower ($\geq$ 92 mg/dL) compared to the non-pregnant cutoff ($\geq$ 100 mg/dL/126 mg/dL).
  5. Macrosomia vs. LGA: Macrosomia usually refers to an absolute birth weight (e.g., >4000g), while Large for Gestational Age (LGA) refers to a weight above the 90th percentile for a specific AOG.
  6. Fetal Kick Counting (Normal vs. Abnormal): 10 movements within 2 hours is normal; fewer movements require further biophysical evaluation.
  7. Insulin vs. Glucose Placental Transfer: Glucose crosses the placenta easily (facilitated diffusion), causing fetal hyperglycemia; Insulin does NOT cross the placenta.
  8. Maternal Hypoglycemia vs. Neonatal Hypoglycemia: Maternal hypoglycemia occurs due to the continuous glucose draw by the fetus; Neonatal hypoglycemia occurs post-delivery because the baby still has high insulin levels but the maternal glucose supply is cut off.
  9. Insulin Regimens (Parkland vs. UAB): Parkland uses a split-dose mix (Breakfast: 2/3 total dose; Dinner: 1/3 total dose), while UAB uses a Basal-Bolus approach (50% long-acting at bedtime; 50% split rapid-acting before meals).
  10. Hypertension in Pregnancy Types: Pregnancy-induced hypertension and preeclampsia are both associated with GDM due to shared vascular damage mechanisms.
  11. Polyhydramnios vs. Polyphagia: Polyhydramnios is an objective sign of excess amniotic fluid; Polyphagia is a subjective symptom of excessive hunger.
  12. Postpartum screening timing: Persistent overt diabetes is checked at 1-3 days post-delivery; GDM re-classification is performed at 6-12 weeks postpartum.
  13. CAS vs. Fetal ECHO: The Congenital Anomaly Scan (CAS) is a general head-to-toe survey; the Fetal ECHO is a specialized view looking specifically for cardiac defects (the #1 anomaly).
  14. MODY 1-6 (Obese vs. Autosomal Dominant): One form of Maturity-Onset Diabetes of the Young is common in obese adolescents, while the other is a rare autosomal dominant condition in thin young adults.
  15. Glycolysis vs. Hypoxemia: Excessive glucose metabolism (Glycolysis) in the fetus consumes oxygen; if disproportionate, it leads to fetal hypoxemia and potential stillbirth.

QA

text

DIABETES MELLITUS IN PREGNANCY: OVERVIEW AND COMPARISON

  1. What is the pathogenesis of Type 1 Diabetes? | Pancreatic $\beta$-cell destruction
    Leading to absolute insulin deficiency.
  2. What is the pathogenesis of Type 2 Diabetes? | Insulin resistance
    Ranges from resistance to secretory defect with resistance.
  3. What is the pathogenesis of Gestational Diabetes (GDM)? | Pregnancy-induced insulin resistance
    Accompanied by inadequate $\beta$-cell compensation.
  4. What is the pathogenesis of Overt Diabetes? | Pre-existing Type 2 DM
    Likely undocumented before pregnancy.
  5. When is the typical onset of Type 1 Diabetes? | Before age 30
    Usually clinically apparent.
  6. What lifestyle factors relate to the onset of Type 2 Diabetes? | Lifestyle, obesity, heredofamilial factors.
  7. When is Gestational Diabetes (GDM) typically recognized? | 24-28 weeks
    Onset or first recognition during pregnancy.
  8. When is Overt Diabetes discovered during pregnancy? | 1st trimester
    Discovered for the 1st time during pregnancy.
  9. When is typical screening performed for Type 1 Diabetes? | Before reproductive age
    Identified early in life.
  10. When is Type 2 Diabetes identified relative to pregnancy? | Before or early pregnancy.
  11. What is the universal screening interval for Gestational Diabetes (GDM)? | 24-28 weeks
    Can be earlier if patient is high risk.
  12. How is Overt Diabetes screened at the first prenatal visit? | Fasting Blood Sugar (FBS).
  13. What diagnosis criteria are used for Type 1 and Type 2 Diabetes? | Standard non-pregnant criteria.
  14. What are the IADPSG 75-g OGTT diagnostic values for Gestational Diabetes (GDM)? (3) | FBS $\geq$ 92, 1h $\geq$ 180, 2h $\geq$ 153.
  15. What are the diagnosis criteria for Overt Diabetes? (3) | FBS $\geq$ 126, HbA1c $\geq$ 6.5%, RPG $\geq$ 200.
  16. What is the management requirement for Type 1 Diabetes? | Insulin always required.
  17. What is the initial management for Type 2 Diabetes? | Medical Nutrition Therapy (MNT).
  18. How long is the trial of MNT for Gestational Diabetes (GDM)? | 2 weeks
    Insulin is added if uncontrolled.
  19. What is the immediate pharmacological management for Overt Diabetes? | Insulin or Metformin.

EPIDEMIOLOGY AND RISK FACTORS

  1. What is the GDM prevalence for Filipino women? | 6-20%
    Filipinos are considered a high-risk ethnic group.
  2. Which global population has the highest risk for hyperglycemia? | Southeast Asian race.
  3. How is History of Macrosomia defined by birthweight? | $\geq$ 9 lbs or 4 kg.
  4. What may a History of Macrosomia indicate? | Undiagnosed GDM
    Refers to previous pregnancies.
  5. At what age is Advanced Maternal Age a risk factor for glucose intolerance? | 36 years old.
  6. How does Obesity contribute to GDM pathologically? | Central adiposity
    Release of leptin and proinflammatory cytokines.
  7. What is the BMI cutoff for Obesity in Asians? | BMI $\geq$ 25.
  8. Why is Polycystic Ovary Syndrome (PCOS) a risk factor for GDM? | Underlying insulin resistance.
  9. In unexplained stillbirths, what causes sudden cessation of fetal heartbeat? | Lack of oxygen
    Caused by increased sugar levels.
  10. What level of Persistent glycosuria warrants immediate investigation? | +3 or +4 glucose
    Measured in urine.
  11. How does Strong family history affect DM risk? | Significantly high risk
    Applies if a direct relative has Diabetes Mellitus.

MATERNAL AND FETAL PATHOPHYSIOLOGY

  1. Name the Pregnancy-related hormones that increase insulin resistance. (4) | Progesterone, Growth Hormone, Prolactin, Cortisol.
  2. When do Pregnancy-related hormones peak to maintain fetal growth? | 2nd trimester.
  3. List the Maternal metabolic adaptations to pregnancy. (3) | Fasting hypoglycemia, postprandial hyperglycemia, hyperinsulinemia.
  4. Name the Proinflammatory cytokines that evoke insulin resistance. (3) | TNF-alpha, IL-6, IGF-1.
  5. How does Maternal hyperglycemia affect the fetal pancreas? | Stimulates insulin secretion
    Due to transfer of excess glucose to the fetus.
  6. What is the role of Fetal hyperinsulinemia in macrosomia? | Growth hormone
    Promotes fat deposition and excessive anabolism.
  7. How does Aerobic metabolism of glucose lead to fetal hypoxemia? | Consumes oxygen
    Baby uses excessive oxygen to process high glucose.
  8. Why is GDM screening most effective at 24-28 weeks? | Placental development established
    Placentally-derived glucose elevation is detectable.

SCREENING AND DIAGNOSTIC CRITERIA (IADPSG)

  1. Why is Universal screening recommended for all Filipina women? | High-risk ethnic group.
  2. Under First prenatal visit screening, what FBS is considered normal? | $\leq$ 92 mg%.
  3. Under First prenatal visit screening, what FBS indicates GDM? | 92-125 mg%.
  4. Under First prenatal visit screening, what FBS indicates overt DM? | $\geq$ 126 mg%.
  5. When should Low-risk patients undergo OGTT? | 24-28 weeks gestation.
  6. When should High-risk patients receive a 75-g OGTT? | First prenatal visit
    Even if the initial FBS is normal.
  7. What is the fasting requirement for the 75-g OGTT Procedure? | 6-8 hours.
  8. When is blood collected during a 75-g OGTT? (3) | Baseline, 1 hour, 2 hours.
  9. How many abnormal values are needed for GDM diagnosis under IADPSG Thresholds? | One value.
  10. What is the IADPSG Fasting Blood Sugar threshold for GDM? | $\geq$ 92 mg/dL.
  11. What is the IADPSG 1-hour postprandial threshold for GDM? | $\geq$ 180 mg/dL.
  12. What is the IADPSG 2-hour postprandial threshold for GDM? | $\geq$ 153 mg/dL.
  13. What HbA1c level diagnoses Overt Diabetes in pregnancy? | $\geq$ 6.5%.
  14. What Random Plasma Glucose diagnoses Overt Diabetes? | $\geq$ 200 mg/dL.
  15. When should 75-g OGTT be repeated if signs like polyhydramnios appear? | 32 weeks gestation.
  16. List symptoms that warrant a repeat OGTT at 32 weeks. (5) | Polyhydramnios, macrosomia, polyphagia, polydipsia, polyuria.

MANAGEMENT AND GLUCOSE TARGETS

  1. What is the first-line management for GDM for 2 weeks? | Medical Nutrition Therapy (MNT).
  2. What dietary model is encouraged for GDM? | Pinggang Pinoy
    Small, frequent meals decrease glucose spikes.
  3. In MNT Dietary Composition, what is the recommended carbohydrate %? | 33–40%.
  4. In MNT Dietary Composition, what are the protein and fat %? | Protein ~20%; Fat ~40%.
  5. What may result from very low carbohydrate intake in GDM management? | intrauterine growth restriction (IUGR).
  6. What is the "Gold Standard" for GDM pharmacological management? | Insulin.
  7. Why is Insulin safety high in pregnancy? | Does NOT cross placenta.
  8. What is the CBG Target for Fasting? | $\leq$ 95 mg/dL.
  9. What is the CBG Target for 1-hour postprandial? | $\leq$ 140 mg/dL.
  10. What is the CBG Target for 2-hour postprandial? | $\leq$ 120 mg/dL.
  11. What is the second-line pharmacological option for GDM? | Metformin.
  12. What dose of Folic Acid is recommended by the lecturer? | 5 mg/day.
  13. What dose of Folic Acid is recommended by the book? | 400 $\mu$g/day.
  14. What is the total weight gain guideline for Obese patients (BMI $\ge$ 30)? | 5-9 kg total.
  15. What is the weekly weight gain for Obese patients in the 2nd/3rd trimesters? | 0.21 kg/week.

ANTENATAL SURVEILLANCE AND COMPLICATIONS

  1. What are the most common congenital anomalies in Diabetic pregnancies? | Congenital Heart Defects.
  2. When is a CAS with fetal ECHO indicated for diabetic pregnancies? | 20-24 weeks.
  3. When should Fetal Kick Counting begin? | 26-28 weeks.
  4. What is a normal Fetal Kick Count? | 10 movements in 2 hours.
  5. How often is a Biophysical Profile (BPS) performed for general GDM? | Every 2 weeks
    Starting at 28-37 weeks.
  6. How often is BPS performed if the patient is on insulin? | Twice a week.
  7. What is the dose and timing for Aspirin prophylaxis? | 60-150 mg/day
    12-16 weeks until delivery.
  8. Aspirin is used as prophylaxis for which condition? | Preeclampsia.
  9. List common labor complications of Fetal Macrosomia. (2) | Shoulder Dystocia, Clavicular fracture.
  10. Why does RDS occur in neonates of diabetic mothers? | Delayed lung surfactant formation
    Caused by elevated sugar levels.
  11. List the Neonatal metabolic complications. (3) | Hypoglycemia, hypocalcemia, hypomagnesemia.
  12. What causes Neonatal polycythemia in GDM? | Hyperglycemia-induced blood cell formation
    Results in increased hematocrit.
  13. What causes Hydramnios in diabetic pregnancies? | Hyperglycemia increasing osmolality
    Leads to fluid transfer and increased amniotic fluid.

DELIVERY AND POSTNATAL CARE

  1. What is the delivery timing for well-controlled GDM? | 39 to 39 6/7 weeks.
  2. What is the delivery timing for insulin-treated GDM? | 38-39 weeks.
  3. What is the delivery timing for poorly controlled GDM? | 37-38 weeks.
  4. At what fetal weight is Elective Cesarean Section considered? | $\geq$ 4500 g.
  5. Why is Elective C-section done for macrosomia? | Prevent brachial plexus injury.
  6. When is Postpartum glucose assessment performed? | 6-12 weeks after delivery
    Uses a repeat 75-g, 2-hr OGTT.
  7. What 2-hr OGTT value defines Postpartum DM? | $\geq$ 200 mg/dL.
  8. What is the long-term risk of GDM recurrence as Type 2 DM? | 50-75% likelihood
    Within 15-25 years.

DIFFERENTIATING SIMILAR ENTITIES

  1. Compare GDM vs. Overt DM by typical AOG. | GDM: after 20 weeks.
    Overt DM: before 20 weeks (1st trimester).
  2. Compare GDM vs. Overt DM by FBS diagnosis. | GDM: 92-125 mg/dL.
    Overt DM: $\geq$ 126 mg/dL.
  3. Compare IADPSG vs. ADA OGTT requirements. | IADPSG: One abnormal value.
    ADA: Two abnormal values.
  4. Compare Pregnant vs. Non-pregnant Fasting cutoffs. | Pregnancy: $\geq$ 92 mg/dL.
    Non-pregnant: $\geq$ 100/126 mg/dL.
  5. Compare Macrosomia vs. LGA. | Macrosomia: Absolute weight (>4000g).
    LGA: >90th percentile for AOG.
  6. Compare Normal vs. Abnormal Kick Count. | Normal: 10 movements in 2 hours.
    Abnormal: Fewer movements.
  7. Compare Insulin vs. Glucose placental transfer. | Glucose: Crosses (facilitated diffusion).
    Insulin: Does NOT cross.
  8. What causes Neonatal hypoglycemia post-delivery? | High fetal insulin levels
    Maternal glucose supply is suddenly cut off.
  9. Contrast Parkland vs. UAB insulin regimens. | Parkland: Split-dose mix (2/3 AM, 1/3 PM).
    UAB: Basal-Bolus approach.
  10. Why is Hypertension associated with GDM? | Shared vascular damage mechanisms.
  11. Define Polyhydramnios vs. Polyphagia. | Polyhydramnios: Excess amniotic fluid.
    Polyphagia: Excessive hunger.
  12. Compare Postpartum screening timing for overt DM vs. GDM. | Overt DM: 1-3 days.
    GDM re-classification: 6-12 weeks.
  13. Define CAS vs. Fetal ECHO scope. | CAS: General survey.
    Fetal ECHO: Cardiac specific (anomaly #1).
  14. Contrast the two presentations of MODY. | Type 1: Obese adolescents.
    Type 2: Rare autosomal dominant in thin adults.
  15. How does excessive Glycolysis lead to stillbirth? | Consumption of oxygen
    Leads to fetal hypoxemia.

8.4 - Endocrine Disorders

Summary

text

SYSTEMATIC SUMMARY OF ENDOCRINE DISORDERS IN PREGNANCY

FeatureHyperthyroidism (Graves')Hypothyroidism (Hashimoto's)
PathogenesisAutoimmune; TSH-receptor antibodies stimulate thyroid; worsened by hCG in 1st trimester.Autoimmune destruction via anti-TPO antibodies; glandular destruction.
Diagnosissuppressed TSH, elevated fT4. (Rarely T3 toxicosis).Elevated TSH, low fT4.
High-Yield FindingsExophthalmos, thyromegaly, failure to gain weight, tachycardia.Symptoms often overlap with normal pregnancy (fatigue, weight gain).
Maternal RisksPreeclampsia, Heart failure (thyrotoxic cardiomyopathy), Thyroid storm.Preeclampsia, placental abruption, cardiac dysfunction.
Fetal RisksPreterm birth, Fetal Growth Restriction (FGR), Stillbirth, Neonatal Graves' (1%).Infertility, miscarriage, stillbirth, low birthweight (<2000g).
Management1st Tri: PTU; 2nd/3rd Tri: Methimazole. Goal: High-normal fT4.Levothyroxine (1-2μg/kg/d). Goal: TSH ~2.5 mU/L.
FeatureCushing's SyndromeAdrenal Insufficiency (Addison's)
Primary CausePregnancy: Autonomous Adrenal Adenoma (mostly).Global: Autoimmune; Philippines/Poor areas: Tuberculosis.
Clinical FeaturesHypertension, DM, preeclampsia, cushingoid facies.Hypotension, nausea, weakness, skin hyperpigmentation.
DiagnosisElevated 24-hr urine free cortisol (UFC), suppressed ACTH.Blunted cortisol response to insulin hypoglycemia/ACTH.
TreatmentSurgical Adrenalectomy (Definitive); medical is second-line.Corticosteroid replacement (must increase dose for "Stress Dose" in labor).
FeatureCentral Diabetes InsipidusNephrogenic Diabetes InsipidusGestational Diabetes Insipidus
EtiologyADH deficiency (Hypothalamus/Pituitary lesion).Renal resistance to ADH at the tubules.Increased ADH degradation by placental vasopressinase.
Water Deprivation TestIncreased urine osmolality after Desmopressin.No change in urine osmolality after Desmopressin.Transient; occurs in late 3rd trimester.
Assoc. ConditionsTrauma, tumor, infection.Hereditary (mostly males); rare in females.Preeclampsia, HELLP, Acute Fatty Liver of Pregnancy (AFLP).

ENDOCRINE PHYSIOLOGY BULLET POINTS

  • Maternal endocrine physiology is constantly changed across pregnancy, partially due to the development of the maternal-fetal unit in the placenta which acts as a temporary gland.
  • First trimester hCG acts as a strong stimulator for TSH receptors, resulting in increased thyroid function and a mirroring decrease in TSH levels.
  • Gestational thyrotoxicosis is the clinical condition where TSH is decreased because of high hCG levels; TSH typically increases back to normal after 12 weeks as hCG decreases.
  • Total thyroxine (T4) increases early in pregnancy due to increased liver synthesis of thyroxin-binding globulin (TBG) stimulated by high placental estradiol.
  • Free thyroxine (fT4) should be maintained at the upper limit of the nonpregnant reference range to be considered normal for healthy pregnant women.
  • Maternal thyroid hormones pass through the placenta in small amounts as early as 6 weeks and are critical for embryogenesis and fetal brain development.
  • Biologically inactive rT3 is produced by type III deiodinase in the placenta, which inactivates maternal T4; this activity increases in the second half of pregnancy.
  • Maternal Thyrotropin-releasing hormone (TRH) can cross the placenta and is also synthesized by the placenta to stimulate fetal pituitary thyroid function.
  • Maternal TSH does not cross the placenta and has no direct effect on the fetus.
  • Fetal thyroid gland starts functioning after 12 weeks of gestation but remains dependent on maternal thyroxine for 30% of its needs at term.
  • Thyroxine-binding globulin (TBG) levels are affected by maternal nutrition; TBG binds fT4, decreasing its bioavailability.
  • The Pituitary Gland is considered the "Master Gland," while the thyroid is the central gland in metabolic regulation.
  • Regulatory positive feedback in the HPO axis occurs when a mid-cycle surge in estrogen stimulates LH release, triggering ovulation.

HYPERTHYROIDISM AND THYROID STORM

  • Most common cause of thyrotoxicosis in pregnancy is Graves' Disease, an autoimmune disorder featuring TSH-receptor antibodies.
  • Clinical hyperthyroidism diagnosis is suggested by excessive tachycardia, thyromegaly, exophthalmos, and weight loss despite adequate intake.
  • Adverse pregnancy outcomes linked to poorly controlled hyperthyroidism include miscarriage, preterm birth, preeclampsia, and heart failure.
  • Offspring of hyperthyroid mothers face higher risks of epilepsy and autism spectrum disorders.
  • Growth restriction occurs in hypermetabolic mothers because the mother consumes massive energy for her own metabolic processes, leaving insufficient nutrients/oxygen for the fetus.
  • Fetal goiter can occur even if the mother is euthyroid because testing only captures maternal levels and not fetal thyroid status.
  • Subclinical hyperthyroidism is characterized by low TSH and normal T4; it generally requires no antithyroid treatment due to potential fetal risks.
  • Rare but life-threatening Thyroid Storm is a hypermetabolic state that can lead to pulmonary hypertension and heart failure (cardiomyopathy).
  • Propylthiouracil (PTU) is the preferred thionamide for the first trimester because it has less placental transfer and inhibits T4 to T3 conversion, despite the FDA warning for hepatotoxicity.
  • Methimazole (MMI) is preferred after 16 weeks of gestation; its use in the first trimester is avoided due to rare embryopathy like aplasia cutis or choanal atresia.
  • Switching from PTU to MMI is done at a 20:1 dose ratio.
  • Thyroidectomy in pregnancy is only recommended in the 2nd trimester if medical therapy is toxic or fails (e.g., doses >450mg/day PTU).
  • Radioactive iodine (RAI) is strictly contraindicated in pregnancy as it can destroy the fetal thyroid gland.
  • Management of thyroid storm (Parkland Hospital protocol) involves loading PTU (1000 mg), followed by iodine (e.g., Sodium iodide/Lugol's) after 1-2 hours, and potential dexamethasone.
  • Gestational Transient Thyrotoxicosis (GTT) is caused by hCG stimulating TSH receptors; it requires no antithyroid drug treatment and normalizes by mid-pregnancy.
  • Molar pregnancy causes T4 elevation in 25-65% of cases because the excess hCG overstimulates TSH receptors; normalization follows molar evacuation.

HYPOTHYROIDISM AND IODINE

  • Hashimoto thyroiditis is the most common cause of hypothyroidism in pregnancy, evidenced by anti-TPO antibodies.
  • Overt hypothyroidism is confirmed by an abnormally high TSH and an abnormally low T4.
  • Severe maternal hypothyroidism is associated with infertility, higher miscarriage rates, and a twofold greater risk of severe preeclampsia.
  • Metabolic syndrome is found in 36% of adult Filipinos with hypothyroidism, significantly increasing the presence of DM and hypertension.
  • Levothyroxine dosing for overt hypothyroidism is 1-2μg/kg/d (approx 100μg/day), with higher requirements starting as early as 5 weeks' gestation.
  • Monitoring of TSH during hypothyroidism treatment should occur every 4 weeks in the first half of pregnancy and at least once in the third trimester.
  • Isolated maternal hypothyroxemia features normal TSH but low free T4; current guidelines recommend against routine treatment.
  • Euthyroid autoimmune thyroid disease (positive anti-TPO with normal TSH/T4) is associated with a 2-5x increased risk of early pregnancy loss and preterm birth.
  • Iodine requirements are higher in pregnancy (220-250 μg/day) due to increased thyroid hormone production, renal losses, and fetal needs.
  • Severe iodine deficiency is associated with endemic cretinism; the ATA advises against exceeding 500 μg/day (twice the recommended intake).
  • Early thyroxine replacement is critical for newborns with Congenital Hypothyroidism to prevent neurological damage.

THYROIDITIS, NODULES, AND CANCER

  • Postpartum thyroiditis occurs in 5-10% of women within the first year after childbirth; it presents initially as a thyrotoxic phase followed by a hypothyroid phase.
  • Thyrotoxic phase of postpartum thyroiditis (1-4 months PP) is caused by hormone release from glandular disruption and is treated with beta-blockers if symptoms are severe.
  • Hypothyroid phase of postpartum thyroiditis (4-8 months PP) is more symptomatic and requires levothyroxine (25-75 μg/day) for 6-12 months.
  • Palpable thyroid nodules found in pregnancy require Fine-needle aspiration (FNA) under ultrasound guidance as pregnancy does not affect cytological diagnosis.
  • Solitary thyroid nodules are 90-95% benign; biopsy is recommended for nodules >5 mm persistent at 3 months post-delivery.
  • Surgery for thyroid cancer is deferred until postpartum if the cancer is non-aggressive or diagnosed in the third trimester; surgery is performed in the 1st/2nd trimester for aggressive cases.
  • Papillary thyroid cancer is the most common thyroid cancer; it is usually slow-growing and non-invasive.

PARATHYROID DISORDERS

  • Calcium homeostasis during pregnancy is maintained by Parathyroid hormone (PTH) and 1,25-dihydroxyvitamin D (calcitriol).
  • Elemental calcium requirement is 1.5-2 g daily from the 20th week of gestation until the end of pregnancy (WHO).
  • Primary hyperparathyroidism (PHPT) is mostly caused by a single parathyroid adenoma; in the Philippines, it is predominantly diagnosed when overtly symptomatic.
  • Hypercalcemic crisis (Ca >14 mg/dL) is a postpartum risk of hyperparathyroidism characterized by nausea, vomiting, and mental status changes.
  • Maternal hyperparathyroidism suppresses the fetal parathyroid gland, leading to a 15-25% incidence of severe neonatal hypocalcemia/tetany after birth.
  • Surgical removal of a symptomatic parathyroid adenoma is the preferred treatment, ideally performed in the 2nd trimester.
  • Emergency treatment for severe hypercalcemia involves IV normal saline diuresis, furosemide, and calcitonin to decrease skeletal calcium release.
  • Hypoparathyroidism symptoms include neuromuscular manifestations like numbness, tingling, and muscle cramps.

ADRENAL AND DISORDERS

  • Cushing's syndrome symptoms like hypertension and DM overlap with pregnancy findings, making late detection common.
  • Active Cushing's syndrome carries a 66% risk of preterm birth and a 52% risk of cesarean delivery.
  • Adrenalectomy surgery remains the definitive cure for Cushing's syndrome caused by an adrenal adenoma.
  • Addison disease (Adrenal Insufficiency) requires increased corticosteroid replacement (stress doses) during labor and delivery to match the normal adrenal response.

PITUITARY DISORDERS

  • Pituitary gland enlarges by approximately one-third during normal pregnancy due to estrogen-induced lactotrophic hyperplasia.
  • Sheehan syndrome is postpartum pituitary necrosis caused by severe hemorrhage/hypovolemic shock; the earliest sign is failure of lactation.
  • Prolactinoma is the most common pituitary tumor in women of childbearing age; complications include amenorrhea, galactorrhea, and visual field defects.
  • Microadenomas (pituitary) are ≤10 mm, while Macroadenomas are >10 mm.
  • Visual field testing (bitemporal hemianopia) is used to detect tumor expansion impinging on the optic chiasm.
  • Bromocriptine is a dopamine-receptor agonist used to restore ovulation in hyperprolactinemic women and to treat symptomatic tumor enlargement during pregnancy.
  • MRI imaging is considered safe for pregnant women needing visualization of pituitary tumors.
  • Acromegaly diagnosis is confirmed by elevated IGF-1 and lack of GH suppression after a glucose load (GH <1 ug/L is normal).
  • Octreotide and pegvisomant are somatostatin and GH analogues used to treat pregnant women with acromegaly.
  • Lymphocytic hypophysitis is a rare autoimmune pituitary disorder that presents close to delivery with headaches and visual disturbances.
  • Desmopressin (dDAVP) is the standard treatment for Central Diabetes Insipidus and is considered safe for the fetus and lactating mothers.
  • Water deprivation test is used to differentiate DI types; nothing by mouth is advised during the test, with hourly measurement of urine tests/body weight.

COMPARISON AND DIFFERENTIATION FOR EXAMS

  • PTU vs. Methimazole: PTU is used in the 1st trimester due to lower placental transfer but has hepatotoxicity risk; MMI is used in 2nd/3rd trimester due to higher potency but is avoided in the 1st trimester due to aplasia cutis risk.
  • TRH vs. TSH: TRH is produced in the placenta and crosses to the fetus; TSH does not cross the placenta.
  • Thyroid Storm vs. Hyperemesis Gravidarum: Both feature tachycardia and vomiting, but Thyroid Storm is a life-threatening hypermetabolic state with decompensation (heart failure), while HG is often transient and TSH/T4 normalize by mid-pregnancy.
  • Graves' Disease vs. Gestational Thyrotoxicosis (GTT): Graves' usually has a pre-pregnancy history, thyromegaly, or exophthalmos and requires thionamides; GTT is transient, hCG-mediated, requires no antithyroid medications, and improves after 12 weeks.
  • Overt Hypothyroidism vs. Subclinical Hypothyroidism: Overt has high TSH and low fT4 and must be treated with levothyroxine (100μg); Subclinical has high TSH but normal fT4 and is treated selectively (e.g., if antibodies present or TSH >10).
  • Central vs. Nephrogenic DI: Central DI responds to Desmopressin (dDAVP) with increased urine osmolality; Nephrogenic DI is resistant to Desmopressin and involves the renal tubules.
  • Diabetes Insipidus vs. Primary Polydipsia: Both feature polyuria/polydipsia, but primary polydipsia is psychogenic and shows a higher response in urine osmolality during Desmopressin testing compared to organic DI.
  • Sheehan Syndrome vs. Prolactinoma: Sheehan syndrome presents with lactation failure and breast atrophy (low prolactin); Prolactinoma features galactorrhea and secondary amenorrhea (high prolactin).
  • Cushing's Syndrome vs. Normal Pregnancy: Both feature weight gain and striae; however, Cushing's is distinguished by more severe hypertension, hyperglycemia, and suppressed ACTH with high UFC.
  • Cushing's Syndrome: Pregnant vs. Non-pregnant: In pregnancy, it is mostly an adrenal adenoma; in non-pregnant adults, 60% is caused by ACTH-dependent pituitary-dependent adrenal hyperplasia.
  • Neonatal Hyperparathyroidism vs. Hypoparathyroidism: Maternal hyperparathyroidism suppresses the fetal gland, leading to transient neonatal hypoparathyroidism (severe hypocalcemia) after birth.
  • Bitemporal Hemianopia vs. Normal Vision: A patient with bitemporal hemianopia (seen in pituitary tumors) can see the medial/central portion but has lost peripheral vision.
  • dDAVP vs. Insulin: dDAVP is safe for the fetus in DI treatment; insulin for DM is also safe but requires closer management for maternal-fetal metabolic side effects.
  • Prolactinoma: Micro vs. Macro: Microadenomas are ≤10mm and rarely enlarge symptomatically in pregnancy (2.4%); Macroadenomas are >10mm and have a 21% risk of symptomatic enlargement.
  • Postpartum Thyroiditis Phases: The Thyrotoxic phase occurs 1-4 months PP (treated with Beta-blockers); the Hypothyroid phase occurs 4-8 months PP (treated with Levothyroxine).
  • TSH-hCG mirroring: In early pregnancy, as hCG rises (peaks at 12 wks), TSH falls; as hCG falls after 12 wks, TSH rises back to baseline.

QA

SYSTEMATIC SUMMARY - THYROID DISORDERS

  1. What is the pathogenesis of Hyperthyroidism (Graves')? | TSH-receptor antibodies.
    Stimulate the thyroid; worsened by hCG in the 1st trimester.
  2. What is the pathogenesis of Hypothyroidism (Hashimoto's)? | Anti-TPO antibodies.
    Causes autoimmune glandular destruction.
  3. What are the diagnostic laboratory findings for Hyperthyroidism (Graves')? | Suppressed TSH, elevated fT4.
  4. What are the diagnostic laboratory findings for Hypothyroidism (Hashimoto's)? | Elevated TSH, low fT4.
  5. What are the high-yield clinical findings (4) for Hyperthyroidism (Graves')? | 1) Exophthalmos
    2) Thyromegaly
    3) Weight gain failure
    4) Tachycardia
  6. Why is Hypothyroidism (Hashimoto's) difficult to diagnose clinically in pregnancy? | Symptom overlap.
    Fatigue and weight gain are common in normal pregnancy.
  7. What are the maternal risks (3) of Hyperthyroidism (Graves')? | 1) Preeclampsia
    2) Heart failure
    3) Thyroid storm
  8. What are the maternal risks (3) of Hypothyroidism (Hashimoto's)? | 1) Preeclampsia
    2) Placental abruption
    3) Cardiac dysfunction
  9. What are the fetal risks (4) of Hyperthyroidism (Graves')? | 1) Preterm birth
    2) FGR
    3) Stillbirth
    4) Neonatal Graves'
  10. What are the fetal risks (4) for Hypothyroidism (Hashimoto's)? | 1) Infertility
    2) Miscarriage
    3) Stillbirth
    4) Low birthweight
  11. What is the trimester-specific management for Hyperthyroidism (Graves')? | 1st: PTU; 2nd/3rd: Methimazole.
    Goal is high-normal fT4.
  12. What is the management and TSH goal for Hypothyroidism (Hashimoto's)? | Levothyroxine (1-2μg/kg/d).
    Goal is TSH ~2.5 mU/L.

SYSTEMATIC SUMMARY - ADRENAL DISORDERS

  1. What is the primary cause of Cushing's Syndrome in pregnancy? | Autonomous Adrenal Adenoma.
  2. What are the primary causes (2) of Adrenal Insufficiency (Addison's)? | Autoimmune (Global) and Tuberculosis (Philippines/Poor areas).
  3. What are the clinical features (4) of Cushing's Syndrome? | 1) Hypertension
    2) DM
    3) Preeclampsia
    4) Cushingoid facies
  4. What are the clinical features (4) of Adrenal Insufficiency (Addison's)? | 1) Hypotension
    2) Nausea
    3) Weakness
    4) Hyperpigmentation
  5. How is Cushing's Syndrome diagnosed? | Elevated 24-hr UFC.
    Accompanied by suppressed ACTH.
  6. How is Adrenal Insufficiency (Addison's) diagnosed? | Blunted cortisol response.
    Occurs after insulin hypoglycemia or ACTH stimulation.
  7. What is the definitive treatment for Cushing's Syndrome? | Surgical Adrenalectomy.
  8. What is the treatment for Adrenal Insufficiency (Addison's) during labor? | Stress dose corticosteroids.
    Must increase dose to match labor stress.

SYSTEMATIC SUMMARY - DIABETES INSIPIDUS (DI)

  1. What is the etiology of Central Diabetes Insipidus? | ADH deficiency.
    Due to hypothalamus or pituitary lesions.
  2. What is the etiology of Nephrogenic Diabetes Insipidus? | Renal resistance to ADH.
  3. What is the etiology of Gestational Diabetes Insipidus? | Increased ADH degradation.
    Caused by placental vasopressinase.
  4. How does Central Diabetes Insipidus respond to Desmopressin? | Increased urine osmolality.
  5. How does Nephrogenic Diabetes Insipidus respond to Desmopressin? | No change.
    Urine osmolality remains the same.
  6. When does Gestational Diabetes Insipidus typically occur? | Late 3rd trimester.
    It is a transient condition.
  7. What are the associated conditions (3) for Central Diabetes Insipidus? | trauma, tumor, infection.
  8. What is the primary population for hereditary Nephrogenic Diabetes Insipidus? | Mostly males.
    It is rare in females.
  9. What conditions (3) are associated with Gestational Diabetes Insipidus? | 1) Preeclampsia
    2) HELLP
    3) AFLP

ENDOCRINE PHYSIOLOGY BULLET POINTS

  1. Why does maternal endocrine physiology change during pregnancy? | Maternal-fetal unit development.
    The placenta acts as a temporary gland.
  2. How does hCG affect thyroid function in the first trimester? | Stimulates TSH receptors.
    Results in increased thyroid function and decreased TSH.
  3. Define Gestational thyrotoxicosis. | Decreased TSH via high hCG.
    TSH typically normalizes after 12 weeks.
  4. Why does total thyroxine (T4) increase early in pregnancy? | Increased TBG synthesis.
    Stimulated by high placental estradiol in the liver.
  5. What is the target level for free thyroxine (fT4) in healthy pregnant women? | Upper limit.
    Target is the upper limit of the nonpregnant reference range.
  6. When do maternal thyroid hormones first cross the placenta? | As early as 6 weeks.
    Crucial for fetal brain development.
  7. What is the function of rT3 (reverse T3) in the placenta? | Inactivating maternal T4.
    Produced by type III deiodinase.
  8. Does maternal Thyrotropin-releasing hormone (TRH) cross the placenta? | Yes.
    Also synthesized by the placenta to stimulate fetal thyroid.
  9. Does maternal TSH cross the placenta? | No.
    It has no direct effect on the fetus.
  10. At what week does the fetal thyroid gland start functioning? | After 12 weeks.
    Still depends on mother for 30% of thyroxine at term.
  11. How does maternal nutrition affect Thyroxine-binding globulin (TBG)? | Affects TBG levels.
    TBG binds fT4, decreasing its bioavailability.
  12. Which gland is considered the Pituitary Gland vs. the thyroid? | Pituitary is "Master Gland".
    Thyroid is central for metabolic regulation.
  13. When does positive feedback occur in the HPO axis? | Mid-cycle estrogen surge.
    Stimulates LH release to trigger ovulation.

HYPERTHYROIDISM AND THYROID STORM

  1. What is the most common cause of thyrotoxicosis in pregnancy? | Graves' Disease.
  2. What clinical signs (4) suggest hyperthyroidism? | 1) Tachycardia
    2) Thyromegaly
    3) Exophthalmos
    4) Weight loss
  3. List pregnancy outcomes of poorly controlled hyperthyroidism. (4) | 1) Miscarriage
    2) Preterm birth
    3) Preeclampsia
    4) Heart failure
  4. What neurodevelopmental risks do offspring of hyperthyroid mothers face? | Epilepsy and Autism.
  5. Why does fetal growth restriction occur in hypermetabolic mothers? | Maternal energy consumption.
    Mother consumes nutrients leaving insufficient amounts for the fetus.
  6. Can a fetal goiter occur if the mother is euthyroid? | Yes.
    Maternal testing may not reflect fetal thyroid status.
  7. What labs define subclinical hyperthyroidism? | Low TSH, normal T4.
  8. What life-threatening state leads to Thyroid Storm complications? | Hypermetabolic state.
    Leads to pulmonary hypertension and heart failure.
  9. Why is Propylthiouracil (PTU) preferred in the 1st trimester? | Less placental transfer.
    Inhibits T4 to T3 conversion.
  10. Why is Methimazole (MMI) avoided in the 1st trimester? | Rare embryopathy.
    Risk of aplasia cutis or choanal atresia.
  11. What is the dose ratio for switching PTU to MMI? | 20:1 ratio.
  12. When is thyroidectomy recommended during pregnancy? | 2nd trimester.
    Only if medical therapy fails or is toxic.
  13. Why is radioactive iodine (RAI) contraindicated in pregnancy? | Destroys fetal thyroid.
  14. What is the first-line drug and dose for thyroid storm management? | PTU 1000 mg (loading).
    Followed by iodine after 1-2 hours.
  15. What causes Gestational Transient Thyrotoxicosis (GTT)? | hCG stimulating TSH receptors.
  16. Why does molar pregnancy cause T4 elevation? | Excess hCG.
    Overstimulates TSH receptors; normalizes after evacuation.

HYPOTHYROIDISM AND IODINE

  1. What is the most common cause of Hashimoto thyroiditis? | Anti-TPO antibodies.
  2. What lab values confirm overt hypothyroidism? | High TSH, low T4.
  3. What risks (3) are associated with severe maternal hypothyroidism? | 1) Infertility
    2) Miscarriage
    3) Severe preeclampsia
  4. What percentage of hypothyroid Filipinos have metabolic syndrome? | 36%.
  5. What is the standard levothyroxine dosing for overt hypothyroidism? | 1-2μg/kg/d (approx 100μg/day).
  6. How often should TSH monitoring occur during treatment? | Every 4 weeks.
    In the first half of pregnancy.
  7. Define isolated maternal hypothyroxemia. | Normal TSH, low fT4.
  8. What are the risks of euthyroid autoimmune thyroid disease? | Pregnancy loss and preterm birth.
    (Positive anti-TPO with normal TSH/T4).
  9. What are the iodine requirements in pregnancy? | 220-250 μg/day.
  10. What condition results from severe iodine deficiency? | Endemic cretinism.
  11. Why is early thyroxine replacement critical in newborns? | Prevents neurological damage.
    Used for Congenital Hypothyroidism.

THYROIDITIS, NODULES, AND CANCER

  1. When does postpartum thyroiditis typically occur? | Within the first year.
    Features a thyrotoxic phase then a hypothyroid phase.
  2. How is the thyrotoxic phase of postpartum thyroiditis treated? | Beta-blockers.
    Treats symptoms of hormone release.
  3. How long is levothyroxine given for the hypothyroid phase of thyroiditis? | 6-12 months.
    (Dose: 25-75 μg/day).
  4. What is the preferred diagnostic test for thyroid nodules in pregnancy? | Fine-needle aspiration (FNA).
  5. A biopsy is recommended for solitary thyroid nodules if they are what size? | >5 mm persistent at 3 months PP.
  6. When is surgery for thyroid cancer performed if diagnosed in the 3rd trimester? | Deferred until postpartum.
    Unless it is aggressive.
  7. What is the most common and non-invasive type of thyroid cancer? | Papillary thyroid cancer.

PARATHYROID DISORDERS

  1. Which two factors maintain calcium homeostasis? | PTH and Calcitriol (1,25-dihydroxyvit D).
  2. What is the WHO recommendation for elemental calcium daily intake? | 1.5-2 g daily.
    From 20th week until term.
  3. What is the most common cause of primary hyperparathyroidism? | Single parathyroid adenoma.
  4. What are the symptoms (3) of a hypercalcemic crisis? | Nausea, vomiting, mental status changes.
  5. Maternal hyperparathyroidism causes neonatal hypocalcemia via what mechanism? | Suppression of fetal parathyroid gland.
  6. When is surgical removal of a parathyroid adenoma best performed? | 2nd trimester.
  7. Name the emergency treatment for severe hypercalcemia. (3) | 1) IV Saline diuresis
    2) Furosemide
    3) Calcitonin
  8. What are the neuromuscular symptoms of hypoparathyroidism? | Numbness, tingling, muscle cramps.

ADRENAL DISORDERS

  1. Why is Cushing's syndrome detection often late in pregnancy? | Symptom overlap.
    Hypertension and DM overlap with normal pregnancy findings.
  2. Active Cushing's syndrome increases the risk of what? (2) | Preterm birth (66%) and Cesarean (52%).
  3. What is the cure for Cushing's syndrome via adrenal adenoma? | Adrenalectomy.
  4. Addison disease management during labor requires what? | Stress dose corticosteroids.

PITUITARY DISORDERS

  1. Why does the pituitary gland enlarge in pregnancy? | Lactotrophic hyperplasia.
    Induced by estrogen.
  2. What is the earliest sign of Sheehan syndrome? | Failure of lactation.
    Caused by postpartum pituitary necrosis.
  3. What are the complications (3) of a prolactinoma? | 1) Amenorrhea
    2) Galactorrhea
    3) Visual field defects
  4. Differentiate Microadenomas vs Macroadenomas by size. | Micro ≤10 mm; Macro >10 mm.
  5. What specific visual defect is seen in pituitary tumor expansion? | Bitemporal hemianopia.
  6. Use of Bromocriptine in hyperprolactinemic women. | Restores ovulation.
    Also treats symptomatic tumor enlargement.
  7. Is MRI imaging safe for visualizing pituitary tumors in pregnancy? | Yes.
  8. How is Acromegaly diagnosis confirmed? | Elevated IGF-1.
    Lack of GH suppression after glucose load.
  9. Name the drugs used for acromegaly in pregnant women. | Octreotide and pegvisomant.
  10. When does lymphocytic hypophysitis usually present? | Close to delivery.
    Presents with headaches and visual disturbances.
  11. Why is Desmopressin (dDAVP) used in DI? | ADH replacement.
    Standard treatment for Central DI.
  12. What is mandatory during a water deprivation test? | Nothing by mouth (NPO).
    Hourly urine/weight monitoring.

COMPARISONS

  1. Compare PTU vs. Methimazole trimester use. | PTU (1st Tri); MMI (2nd/3rd Tri).
  2. Compare TRH vs. TSH placental transfer. | TRH crosses; TSH does not.
  3. Differentiate Thyroid Storm vs. Hyperemesis Gravidarum. | Storm is life-threatening/decompensated.
    HG is transient; TSH normalizes mid-pregnancy.
  4. Differentiate Graves' vs. Gestational Thyrotoxicosis (GTT). | Graves' needs thionamides/history.
    GTT is hCG-mediated/transient.
  5. Overt vs. Subclinical Hypothyroidism labs. | Overt: High TSH, Low fT4.
    Subclinical: High TSH, Normal fT4.
  6. Central vs. Nephrogenic DI Desmopressin response. | Central responds; Nephrogenic is resistant.
  7. DI vs. Primary Polydipsia. | Polydipsia is psychogenic.
    Shows higher urine osmolality response to dDAVP.
  8. Sheehan Syndrome vs. Prolactinoma prolactin levels. | Sheehan: Low prolactin.
    Prolactinoma: High prolactin.
  9. Cushing's vs. Normal Pregnancy symptoms. | Cushing's is more severe.
    Features high UFC and suppressed ACTH.
  10. Cushing's Syndrome Cause: Pregnant vs Non-pregnant. | Pregnant: Adrenal Adenoma.
    Non-pregnant: Pituitary-dependent hyperplasia.
  11. Neonatal Hyper- vs Hypoparathyroidism. | Maternal Hyper causes Neonatal Hypo.
  12. Define Bitemporal Hemianopia vision loss. | Loss of peripheral vision.
    Medial/central vision remains intact.
  13. dDAVP vs. Insulin safety. | Both are generally safe.
  14. Prolactinoma risk of enlargement: Micro vs Macro. | Micro (2.4%); Macro (21%).
  15. Timing of Postpartum Thyroiditis Phases. | Thyrotoxic: 1-4 months PP.
    Hypothyroid: 4-8 months PP.
  16. Explain TSH-hCG mirroring. | As hCG rises, TSH falls.
    As hCG falls, TSH rises back.

8.5 - Connective Tissue Disorders

Summary

text

CONNECTIVE TISSUE DISORDERS (CTDs) IN PREGNANCY

I. GENERAL EPIDEMIOLOGY AND FILIPINO CONTEXT

CategoryCharacteristicDetailed Findings
Hereditary CTDsPathogenesisTypically inherited in a typical Mendelian form as an autosomal dominant trait affecting males and females equally.
Autoimmune CTDsPathogenesisAcquired rather than inherited, but with genetic predispositions and familial tendencies triggered by external factors.
MCTD (Filipinos)DemographicsAccording to a PGH review, Mixed Connective Tissue Disease (MCTD) is predominantly seen in females with a median age of onset around 30.5 years.
MCTD (Filipino)Clinical PresentationThe most common chief complaint in Mixed Connective Tissue Disease (MCTD) among Filipinos is joint pain (67%), followed by skin tightness (13%).
MCTD (Filipino)Initial DiagnosisSystemic lupus erythematosus (SLE) was the most frequent initial diagnosis (43%) in patients later confirmed to have MCTD.
MCTD (Filipino)Physical FindingsThe hallmark findings for Mixed Connective Tissue Disease (MCTD) involve: Musculoskeletal - arthritis (100%), Vascular - Raynaud’s phenomenon (93%), and Cutaneous - skin tightness (71%).

II. SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

FeatureDescription
DefinitionA chronic, multisystem inflammatory autoimmune disease characterized by relapses (flares) and remissions.
Entry CriterionTo classify for Systemic Lupus Erythematosus (SLE), the patient must have Antinuclear antibodies (ANA) at a titer of ≥1:80 on HEp-2 cells; if absent, do not classify as SLE.
Scoring GoalAfter confirming ANA positivity, a total score of 10 points or more from clinical and immunologic domains is required for SLE classification.
Renal FindingsIn the classification of Systemic Lupus Erythematosus (SLE), the highest clinical weight (10 points) is given to Class III or IV lupus nephritis on renal biopsy.
Cardiac/SerosalClinical criteria for Systemic Lupus Erythematosus (SLE) include Acute pericarditis (6 points) and pleural or pericardial effusion (5 points).
Skin/MucosaSpecific manifestations for Systemic Lupus Erythematosus (SLE) include the malar rash (photosensitivity), non-scarring alopecia, and oral ulcers.

III. ANTIPHOSPHOLIPID SYNDROME (APS)

AspectData/Criteria
DefinitionAn acquired thrombophilia characterized by recurrent thrombosis or pregnancy morbidity in the presence of specific autoantibodies.
Lab Criteria 1Lupus anticoagulant (LAC) must be present on ≥2 occasions at least 12 weeks apart.
Lab Criteria 2Anticardiolipin antibodies (ACA) IgG/IgM must be at medium-high titers (>40 GPL/MPL) on ≥2 occasions 12 weeks apart.
Lab Criteria 3Anti-beta-2 glycoprotein I antibody IgG/IgM must be >99th percentile on ≥2 occasions 12 weeks apart.
Obstetric Criteria1) ≥1 death of a normal fetus at ≥10 weeks; 2) ≥1 preterm birth <34 weeks due to severe preeclampsia/placental insufficiency; 3) ≥3 consecutive abortions <10 weeks.
PathogenesisBeta-2 Glycoprotein-I is expressed in high concentrations on the syncytiotrophoblast; antibodies reverse its natural anticoagulant activity, promoting thrombosis.
SyncytiotrophoblastUnique to pregnancy, Antiphospholipid Syndrome (APS) inhibits syncytiotrophoblast differentiation (SYNCI), potentially making delivery the definitive treatment.

IV. RHEUMATOID ARTHRITIS (RA) & SYSTEMIC SCLEROSIS

TopicKey Findings
RA SymptomsUp to 70% of women with Rheumatoid Arthritis (RA) experience symptom improvement during pregnancy, likely due to HLA disparity between mother and fetus.
RA PostpartumA flare-up or exacerbation of Rheumatoid Arthritis (RA) occurs in 40-50% of women following delivery.
RA DiagnosisClassification of Rheumatoid Arthritis (RA) is score-based (score ≥6); criteria include joint involvement (small joints weighted higher), RF/ACPA titers, and ESR/CRP levels.
RA TreatmentMethotrexate must be strictly avoided as it causes abortion; patients should be screened for pregnancy before use.
Sclerosis HallmarkThe pathognomonic feature of Systemic Sclerosis is the excessive deposition and overproduction of normal collagen in skin and internal organs.
CREST SyndromeA variant of systemic sclerosis including Calcinosis, Raynaud’s, Esophageal involvement, Sclerodactyly, and Telangiectasia.
Sclerosis DeathThe leading cause of death in Systemic Sclerosis is Pulmonary Arterial Hypertension (PAH), affecting 15% of patients.

V. INHERITED DISORDERS (MARFAN, OI, EDS)

DiseasePathophysiology & Risks
Marfan SyndromeCaused by a mutation in the FBN1 gene on chromosome 15q21 encoding fibrillin-1.
Marfan ComplicationThe most serious and frequent pregnancy-related complication in Marfan Syndrome is Aortic Dissection (AoD).
EDS Types I-IIIEhlers-Danlos Syndrome (hEDS) is generally well-tolerated in pregnancy but carries risks of joint hypermobility and skin fragility.
EDS Type IVThe vascular type of Ehlers-Danlos Syndrome (EDS Type IV) is high-risk, predisposed to great vessel rupture and uterine rupture.
OI FeaturesOsteogenesis Imperfecta (OI) is characterized by brittle bones, blue sclerae, and hearing loss.
OI Type IIOsteogenesis Imperfecta Type II is the most severe form and is typically lethal in utero.

COMPREHENSIVE BULLET POINTS (REPRESENTATIVE FOR FLASHCARDS)

  • In Mixed Connective Tissue Disease (MCTD), the Alarcon-Segovia Criteria is used for diagnosis, and high titers of anti-U1RNP are characteristic findings.
  • Patients with Systemic Lupus Erythematosus (SLE) have placentas that are typically smaller with vascular lesions like decidual vasculopathy, thrombosis, and infarction.
  • Neonatal Lupus Erythematosus (NLE) is caused by the transplacental passage of maternal anti-SSA (Ro) or anti-SSB (La) autoantibodies.
  • The most common manifestation of Neonatal Lupus (NLE) is a photosensitive skin rash, which usually resolves within 3 to 6 months as maternal antibodies clear.
  • A permanent and serious complication of Neonatal Lupus (NLE) is congenital heart block (CHB), though the lecturer notes this was not seen in the specific Filipino study reviewed.
  • Hydroxychloroquine (HCQ) is the only maternal treatment for SLE that has been shown to lower the risk of Neonatal Lupus.
  • For pregnant women with Systemic Lupus Erythematosus (SLE), non-fluorinated corticosteroids (Prednisone, Hydrocortisone) are preferred because they are inactivated by the placenta.
  • Aspirin at 81mg/day should be initiated at 12 weeks of gestation in all SLE patients to decrease the occurrence of preeclampsia.
  • Lupus flares in pregnancy are often difficult to distinguish from preeclampsia; however, decreased complement levels (C3, C4) and increased anti-dsDNA titers strongly suggest a flare.
  • The Lupus Anticoagulant (LAC) is the only antiphospholipid antibody consistently associated with adverse pregnancy outcomes despite being named an "anticoagulant" due to its in vitro effects.
  • Annexin V is a natural anticoagulant expressed by the syncytiotrophoblast that may be targeted by pathogenetic antibodies in Antiphospholipid Syndrome (APS).
  • Catastrophic Antiphospholipid Antibody Syndrome (CAPS), also known as Asherson Syndrome, involves a "cytokine storm" affecting three or more organ systems and has a high mortality rate.
  • Heparin (UFH or LMWH) is the mainstay for thrombosis prevention in Antiphospholipid Syndrome (APS) because it prevents cellular damage by binding to beta-2-glycoprotein-I.
  • Warfarin is strictly avoided during pregnancy in Antiphospholipid Syndrome (APS) management because it is a Vitamin K antagonist that is teratogenic and causes fetal bleeding.
  • Symptom improvement in Rheumatoid Arthritis (RA) during pregnancy is correlated with higher serum levels of pregnancy-associated alpha2-glycoprotein (PAG).
  • In Systemic Sclerosis, Labetalol must be avoided for hypertension management because it can cause peripheral vasospasm.
  • Captopril (ACE inhibitor) is the treatment of choice if a Scleroderma Renal Crisis (SRC) is suspected, though typically used post-natally unless life-threatening.
  • Polyarteritis Nodosa (PAN) is a necrotizing vasculitis of small and medium-sized arteries that may present peripartum with tender subcutaneous nodules and myositis.
  • Marfan Syndrome risk is highest during the third trimester and postpartum due to cardiovascular changes like increased stroke volume and hormonal wall changes.
  • In Ehlers-Danlos Syndrome (EDS), patients are at high risk for postpartum hemorrhage (PPH) and should receive prompt episiotomies to prevent irregular perineal tears.
  • Osteogenesis Imperfecta (OI) patients may experience a fracture rate increase in the third trimester due to pregnancy-induced bone loss and transient decreases in bone mineral density.
  • Pregnancy is generally discouraged in patients with severe CTD manifestations, specifically those with pulmonary hypertension or recent stroke.
  • Methotrexate and Mycophenolate Mofetil must be discontinued 1-3 months and 6 weeks respectively before attempting pregnancy due to high teratogenic risk.

DIFFERENTIATING SIMILAR ENTITIES (FOR EXAMS)

  • Lupus Flare vs. Preeclampsia: In Lupus Flare, complement levels (C3/C4) are decreased and anti-dsDNA is increased; in Preeclampsia, complements are usually normal and anti-dsDNA is negative.
  • Lupus Flare vs. Preeclampsia: Urinary cellular casts and hematuria are highly characteristic of an SLE renal flare, whereas they are absent in pure preeclampsia.
  • Lupus Flare vs. Preeclampsia: Uric acid is typically elevated in preeclampsia but remains normal in an SLE flare.
  • Chronic Arterial vs. Venous Insufficiency: Arterial insufficiency presents with decreased/absent pulses and pale skin on elevation; Venous insufficiency has normal pulses and brown skin pigmentation.
  • Arterial vs. Venous Ulcers: Arterial ulcers occur on toes or trauma points; Venous ulcers occur at the medial ankle.
  • SLE vs. RA: SLE is multisystemic with hallmark malar rash and nephritis; RA is primarily an inflammatory synovitis of peripheral joints.
  • APS Lab Markers: Lupus Anticoagulant (LAC) is the most predictive of pregnancy loss, while Anticardiolipin (ACA) is directed specifically against mitochondrial/platelet membranes.
  • OI Type I vs. Type II: Type I is the mildest form and compatible with successful pregnancy; Type II is typically lethal in the neonatal period or in utero.
  • EDS vs. Marfan: Both involve connective tissue, but Marfan is primarily a fibrillin-1 defect with aortic risks, while EDS is a collagen defect with skin/joint fragility risks.
  • Heparin vs. Aspirin: Heparin inhibits the coagulation cascade (common pathway); Aspirin inhibits platelet aggregation by blocking Thromboxane A2.
  • Systemic Sclerosis (Limited vs. Diffuse): Limited (CREST) is more benign and slow; Diffuse features rapid skin and GI fibrosis.
  • Neonatal Lupus vs. SLE: Neonatal Lupus is a passive transfer of antibodies that resolves (except heart block); SLE is an endogenous autoimmune disease of the patient.
  • Prednisone vs. Dexamethasone: Prednisone is preferred for maternal SLE treatment (placenta inactivates it); Dexamethasone is used only if the goal is to treat the fetus (crosses placenta).
  • Labetalol in CTDs: Preferred in preeclampsia but contraindicated in Scleroderma due to potential to worsen Raynaud's/vasospasm.
  • Thrombosis (APS): Arterial thrombosis often presents as stroke or MI; Venous thrombosis typically presents as DVT or PE.

QA

  1. How is Hereditary Connective Tissue Disorder typically inherited? | Autosomal dominant trait.

  2. Which sexes are equally affected by Hereditary Connective Tissue Disorder? | Males and females.

  3. Contrast the origin of Autoimmune Connective Tissue Disorder vs Hereditary types. | Acquired (not inherited).

  4. What triggers Autoimmune Connective Tissue Disorder in genetically predisposed individuals? | External factors.

  5. In Filipinos, which sex predominantly develops Mixed Connective Tissue Disease (MCTD)? | Females.

  6. What is the median age of onset for Mixed Connective Tissue Disease (MCTD) in Filipinos? | 30.5 years.

  7. What is the most common chief complaint (67%) in Filipino Mixed Connective Tissue Disease (MCTD)? | Joint pain.

  8. What is the second most common complaint (13%) in Filipino Mixed Connective Tissue Disease (MCTD)? | Skin tightness.

  9. What was the most frequent initial diagnosis in Filipino patients later confirmed with Mixed Connective Tissue Disease (MCTD)? | Systemic lupus erythematosus (SLE).

  10. What is the musculoskeletal hallmark (100%) of Mixed Connective Tissue Disease (MCTD)? | Arthritis.

  11. What is the vascular hallmark (93%) of Mixed Connective Tissue Disease (MCTD)? | Raynaud’s phenomenon.

  12. What is the cutaneous hallmark (71%) of Mixed Connective Tissue Disease (MCTD)? | Skin tightness.

  13. How is Systemic Lupus Erythematosus (SLE) defined regarding its clinical course? | Relapses (flares) and remissions.

  14. What is the mandatory entry criterion for Systemic Lupus Erythematosus (SLE) classification? | Antinuclear antibodies (ANA).

  15. What ANA titer on HEp-2 cells is required to classify Systemic Lupus Erythematosus (SLE)? | ≥1:80.

  16. What total score is required for Systemic Lupus Erythematosus (SLE) classification after ANA positivity? | 10 points or more.

  17. Which renal findings carry the highest weight (10 points) in Systemic Lupus Erythematosus (SLE) classification? | Class III/IV lupus nephritis.

  18. What cardiac criterion for Systemic Lupus Erythematosus (SLE) yields 6 points? | Acute pericarditis.

  19. What serosal criterion for Systemic Lupus Erythematosus (SLE) yields 5 points? | Pleural/pericardial effusion.

  20. What specific photosensitive skin manifestation is seen in Systemic Lupus Erythematosus (SLE)? | Malar rash.

  21. What hair-related manifestation is a criterion for Systemic Lupus Erythematosus (SLE)? | Non-scarring alopecia.

  22. What mucosal finding is part of the Systemic Lupus Erythematosus (SLE) clinical criteria? | Oral ulcers.

  23. How is Antiphospholipid Syndrome (APS) defined? | Acquired thrombophilia.

  24. What are the two core clinical features of Antiphospholipid Syndrome (APS)? | Thrombosis or pregnancy morbidity.

  25. How many occasions must Lupus anticoagulant (LAC) be present for APS diagnosis? | ≥2 occasions.

  26. What is the minimum time interval between positive Lupus anticoagulant (LAC) tests? | 12 weeks.

  27. What titers of Anticardiolipin antibodies (ACA) IgG/IgM are required for APS? | Medium-high (>40 GPL/MPL).

  28. How many weeks apart must Anticardiolipin antibodies (ACA) be measured? | 12 weeks.

  29. What percentile threshold is used for Anti-beta-2 glycoprotein I antibody in APS? | >99th percentile.

  30. Define the fetal death criterion for Antiphospholipid Syndrome (APS). | ≥1 death (≥10 weeks).

  31. Define the preterm birth criterion for Antiphospholipid Syndrome (APS). | <34 weeks.

  32. What causes preterm birth in Antiphospholipid Syndrome (APS) criteria? | Preeclampsia/placental insufficiency.

  33. Define the abortion criterion for Antiphospholipid Syndrome (APS). | ≥3 consecutive (<10 weeks).

  34. Where is Beta-2 Glycoprotein-I expressed in high concentrations during pregnancy? | Syncytiotrophoblast.

  35. How do antibodies affect Beta-2 Glycoprotein-I in APS? | Reverse natural anticoagulant activity.

  36. What process is inhibited by Antiphospholipid Syndrome (APS) in the placenta? | Syncytiotrophoblast differentiation (SYNCI).

  37. What may be considered the definitive treatment for Antiphospholipid Syndrome (APS)? | Delivery.

  38. What percentage of Rheumatoid Arthritis (RA) patients improve during pregnancy? | 70%.

  39. What is the likely cause of Rheumatoid Arthritis (RA) improvement in pregnancy? | HLA disparity (mother-fetus).

  40. What percentage of Rheumatoid Arthritis (RA) women experience a postpartum flare-up? | 40-50%.

  41. What is the minimum score required for Rheumatoid Arthritis (RA) classification? | Score ≥6.

  42. Which joints are weighted higher in the Rheumatoid Arthritis (RA) scoring system? | Small joints.

  43. Which lab titers are part of Rheumatoid Arthritis (RA) classification? | RF and ACPA.

  44. Which inflammatory markers are used in Rheumatoid Arthritis (RA) diagnosis? | ESR and CRP.

  45. Why must Methotrexate be strictly avoided in Rheumatoid Arthritis (RA) pregnancy? | Causes abortion.

  46. What screening must be done before starting a Rheumatoid Arthritis (RA) patient on Methotrexate? | Pregnancy screen.

  47. What is the pathognomonic feature of Systemic Sclerosis? | Overproduction of normal collagen.

  48. Enumerate the components of CREST Syndrome. (5) | 1) Calcinosis
    2) Raynaud’s
    3) Esophageal involvement
    4) Sclerodactyly
    5) Telangiectasia

  49. What is the leading cause of death in Systemic Sclerosis? | Pulmonary Arterial Hypertension (PAH).

  50. What percentage of Systemic Sclerosis patients are affected by Pulmonary Arterial Hypertension? | 15%.

  51. Marfan Syndrome is caused by a mutation in which gene? | FBN1 gene.

  52. On which chromosome is the gene for Marfan Syndrome located? | 15q21.

  53. The FBN1 gene in Marfan Syndrome encodes for which protein? | Fibrillin-1.

  54. What is the most serious pregnancy complication in Marfan Syndrome? | Aortic Dissection (AoD).

  55. How is Ehlers-Danlos Syndrome (hEDS) Types I-III generally tolerated in pregnancy? | Well-tolerated.

  56. What are the two main risks for Ehlers-Danlos Syndrome (hEDS) patients in pregnancy? | Joint hypermobility; skin fragility.

  57. Which type of Ehlers-Danlos Syndrome (EDS) is high-risk for maternal vessel/uterine rupture? | Type IV (Vascular).

  58. Enumerate the classic features of Osteogenesis Imperfecta (OI). (3) | 1) Brittle bones
    2) Blue sclerae
    3) Hearing loss

  59. Which type of Osteogenesis Imperfecta (OI) is typically lethal in utero? | Type II.

  60. Which criteria are used for Mixed Connective Tissue Disease (MCTD) diagnosis? | Alarcon-Segovia Criteria.

  61. Which antibody is characteristic of Mixed Connective Tissue Disease (MCTD)? | Anti-U1RNP.

  62. Describe the typical placenta in Systemic Lupus Erythematosus (SLE). | Smaller than normal.

  63. Enumerate the vascular lesions found in Systemic Lupus Erythematosus (SLE) placentas. (3) | 1) Decidual vasculopathy
    2) Thrombosis
    3) Infarction

  64. What causes Neonatal Lupus Erythematosus (NLE)? | Transplacental maternal antibodies.

  65. Which specific antibodies (2) cause Neonatal Lupus Erythematosus (NLE)? | Anti-SSA (Ro); anti-SSB (La).

  66. What is the most common manifestation of Neonatal Lupus (NLE)? | Photosensitive skin rash.

  67. When does the skin rash in Neonatal Lupus (NLE) usually resolve? | 3 to 6 months.

  68. What permanent cardiac complication can occur in Neonatal Lupus (NLE)? | Congenital heart block (CHB).

  69. Which maternal SLE treatment reduces the risk of Neonatal Lupus? | Hydroxychloroquine (HCQ).

  70. Why are non-fluorinated corticosteroids preferred for SLE in pregnancy? | Inactivated by the placenta.

  71. Enumerate the preferred non-fluorinated corticosteroids for SLE. (2) | 1) Prednisone
    2) Hydrocortisone

  72. What dosage of Aspirin is used in SLE to prevent preeclampsia? | 81mg/day.

  73. At what gestational age should Aspirin be initiated for SLE patients? | 12 weeks.

  74. Distinguish Lupus Flare vs. Preeclampsia based on complement (C3, C4). | Flare: Decreased;
    Preeclampsia: Normal.

  75. Distinguish Lupus Flare vs. Preeclampsia based on anti-dsDNA. | Flare: Increased;
    Preeclampsia: Negative.

  76. Which APS antibody is most consistently associated with adverse pregnancy outcomes? | Lupus Anticoagulant (LAC).

  77. Which natural syncytiotrophoblast anticoagulant is targeted in Antiphospholipid Syndrome (APS)? | Annexin V.

  78. What is the alternative name for Catastrophic Antiphospholipid Antibody Syndrome (CAPS)? | Asherson Syndrome.

  79. How many organ systems must be affected for Catastrophic APS (CAPS)? | Three or more.

  80. What is the main treatment for thrombosis prevention in Antiphospholipid Syndrome (APS)? | Heparin (UFH or LMWH).

  81. How does Heparin prevent damage in APS? | Binds to beta-2-glycoprotein-I.

  82. Why is Warfarin strictly avoided in APS during pregnancy? | Teratogenic (fetal bleeding).

  83. Which protein's high serum levels correlate with Rheumatoid Arthritis (RA) improvement? | Pregnancy-associated alpha2-glycoprotein (PAG).

  84. Why is Labetalol avoided in Systemic Sclerosis? | Causes peripheral vasospasm.

  85. What is the treatment of choice for Scleroderma Renal Crisis (SRC)? | Captopril (ACE inhibitor).

  86. Define Polyarteritis Nodosa (PAN). | Necrotizing vasculitis.

  87. Enumerate findings of peripartum Polyarteritis Nodosa (PAN). (2) | 1) Subcutaneous nodules
    2) Myositis

  88. When is the risk of Marfan Syndrome complication highest? | Third trimester and postpartum.

  89. Ehlers-Danlos Syndrome (EDS) patients are at high risk for which delivery complication? | Postpartum hemorrhage (PPH).

  90. What is the recommended management for Ehlers-Danlos Syndrome (EDS) at delivery? | Prompt episiotomy.

  91. Why does Osteogenesis Imperfecta (OI) fracture rate increase in the 3rd trimester? | Pregnancy-induced bone loss.

  92. Severe CTD manifestations (e.g. stroke) result in what recommendation regarding pregnancy? | Pregnancy is discouraged.

  93. How long before attempting pregnancy should Methotrexate be discontinued? | 1-3 months.

  94. How long before attempting pregnancy should Mycophenolate Mofetil be discontinued? | 6 weeks.

  95. Distinguish Lupus Flare vs. Preeclampsia based on urinary findings. | Flare: Cellular casts/hematuria;
    Preeclampsia: Absent.

  96. Distinguish Lupus Flare vs. Preeclampsia based on uric acid levels. | Flare: Normal;
    Preeclampsia: Elevated.

  97. Distinguish Insufficiency (Arterial vs. Venous) based on pulses. | Arterial: Decreased/absent;
    Venous: Normal.

  98. Distinguish Ulcers (Arterial vs. Venous) based on location. | Arterial: Toes/trauma points;
    Venous: Medial ankle.

  99. Compare SLE vs. RA primary pathology. | SLE: Multisystemic/Nephritis;
    RA: Inflammatory synovitis.

  100. Contrast OI Type I vs. Type II pregnancy compatibility. | Type I: Successful pregnancy;
    Type II: Lethal in utero.

  101. Compare Marfan vs. EDS structural defects. | Marfan: Fibrillin-1 (Aortic risk);
    EDS: Collagen (Skin/Joint risk).

  102. Compare Heparin vs. Aspirin inhibition targets. | Heparin: Coagulation cascade;
    Aspirin: Platelet aggregation.

  103. Contrast Systemic Sclerosis (Limited vs. Diffuse) progression. | Limited: Benign/Slow;
    Diffuse: Rapid skin/GI fibrosis.

  104. Contrast Neonatal Lupus vs. SLE origin. | Neonatal: Passive antibody transfer;
    SLE: Endogenous autoimmune.

  105. Compare Prednisone vs. Dexamethasone fetal effect. | Prednisone: Inactivated (maternal use);
    Dexamethasone: Crosses (fetal use).